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1 Summary
Fluorescence Correlation Spectroscopy (FCS) allows one to measure protein-membrane
binding, self-assembly and other molecular reactions and parameters quantitatively in
buffer as well as in complex media. Subject of this thesis was to investigate protein-
membrane interactions within blood coagulation in buffer as well as in their biological
environment with FCS.
Binding of Factor VIII (FVIII) to phosphatidylserine (PS)-expressing platelets is a key
process in the intravascular pathway of the blood coagulation cascade. Representing a
complex component of the highly regulated network of the coagulation cascade, this
protein-membrane interaction is influenced by many cofactors, such as annexin, which
binds to PS-containing membranes as well. Since defects in coagulation, particularly in
FVIII binding to membranes lead to severe bleeding disorders, a better understanding
of the underlying biophysical and biochemical mechanisms and regulatory influences of
this interaction could boost diagnosis and therapy of such diseases, especially when used
in combination with an improved systems biology description of the cascade.
This thesis investigates the mechanism of FVIII binding to PS-containing model mem-
branes and its regulation by annexin using FCS. Activated FVIII, in contrast to inac-
tivated FVIII, was found to exhibit a striking binding anomaly, consisting in a sharply
peaked dependence of the binding constant K(PS) as a function of the PS content. It
exceeds the binding of inactivated FVIII in a regime around 12% PS, including phys-
iological concentrations. Furthermore, the regulatory influence of annexin, which can
both, increase as well as decrease the binding of activated FVIII, was explained based
on this binding anomaly. A quantitative model of this regulatory mechanism assuming
efficient shielding of charges by annexin was developed, which allows for the reconstruc-
tion of the full three-dimensional phase diagram of FVIII binding to membranes as a
function of their PS-content and the concentration of annexin. In order to prove the
relevance of these results for coagulation, the experiments were repeated in plasma.
Since plasma is a scattering medium, which is crowded by macromolecules and hence
strongly affects FCS experiments, a procedure to analyze measurements performed in
such complex media was developed. To this end, the influences of scattering and crowd-
ing on FCS were investigated using a model system of GFP in highly concentrated vesicle
solutions. Scattering was found to enhance and distort the focal volume, whereas crowd-
ing slows down diffusion. Taking both effects into account, corrections could be applied,
which were demonstrated to allow for artifact-free analysis of binding measurements in
complex soft matter systems. To further improve the performance of FCS in complex
media and, particularly, in cells, a two-photon FCS microscope was set up.
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Based on the results of the investigations on scattering and crowding, FCS experiments
on living cells were performed. The effective viscosity in dictyostelium discoideum cells
was probed and compared to values obtained in lysate. The enhancement of viscosity
in the cytoplasm was found to be due to crowding by polydisperse macromolecules,
whereas the viscosity of the actin cortex was determined by actin polymerization. Drug
treatment allowed for regulation of the polymerization level in the cytoplasm and for
detection and determination of the viscosity of actin waves.
A project in close colaboration with the groups of Prof. Bein and Prof. Bra¨uchle
succeded in the design, characterization and testing of a drug delivery system employ-
ing colloidal mesoporous silica nanoparticles efficiently coated by lipids with a solvent
exchange method. Using cross-correlation spectroscopy the lipids were shown to form
a close and dense bilayer around the nanoparticles. In-vitro drug delivery experiments
gave evidence of the capping-mechanism of the lipids and in-vivo studies proved the
efficient delivery and release of drugs by the lipid-coated nanoparticles.
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2 Zusammenfassung
Mit Fluoreszenz-Korrelations-Spektroskopie (FCS) ko¨nnen Protein-Membran-Bindungen
und andere molekulare Reaktionen und Parameter quantitativ auch in komplexen Me-
dien gemessen werden. Inhalt dieser Arbeit war die Untersuchung von Protein-Membran-
Wechselwirkungen bei der Blutgerinnung in Puffer wie auch in biologischer Umgebung
mit Hilfe von FCS.
Die Bindung von Faktor VIII (FVIII) an Blutpla¨ttchen, die Phosphatidylserin (PS)
exprimieren, ist ein wichtiger Bestandteil des intravaskula¨ren Systems der Blutgerin-
nungskaskade. Diese Protein-Membran-Wechselwirkung ist eine komplexe Komponente
des hochregulierten Netzwerks der Blutgerinnungskaskade und ist von vielen Kofaktoren
beeinflusst, wie zum Beispiel von Annexin, das wie FVIII auch an PS-haltige Membra-
nen bindet. Da Sto¨rungen der Gerinnung, insbesondere der FVIII-Bindung an Membra-
nen zu schweren Blutungskrankheiten fu¨hren, ko¨nnte ein besseres Versta¨ndnis der zu-
grundeliegenden biophysikalischen und biochemischen Mechanismen und regulatorischen
Einflu¨sse dieser Wechselwirkung die Diagnose und Therapie solcher Krankheiten wesent-
lich verbessern, besonders in Kombination mit einer dadurch verbesserten system-biolo-
gischen Beschreibung der Gerinnungskaskade.
Diese Arbeit untersucht mit Hilfe von FCS den Mechanismus der FVIII-Bindung an
PS-haltige Modellmembranen und ihre Regulation durch Annexin. Im Gegensatz zu
inaktiviertem FVIII, zeigt aktivierter FVIII eine starke Bindungsanomalie, die sich in
einem scharfen Maximum der PS-Abha¨ngigkeit der Bindungskonstante a¨ussert. Die
Bindungssta¨rke u¨bersteigt die von inaktiviertem FVIII in einem Bereich um 12% PS-
Gehalt, der auch die physiologischen Konzentrationen beinhaltet. Daru¨berhinaus wurde
der regulatorische Einfluss von Annexin, das die Bindung von aktiviertem FVIII sowohl
erho¨hen als auch vermindern kann, mit dieser Bindungsanomalie erkla¨rt. Es wurde
ein quantitatives Modell dieses Regulationsmechanismus entwickelt, das davon ausgeht,
dass Annexin die PS-Ladungen effizient abschirmt. Dieses Modell ermo¨glichte die Rekon-
struktion des vollen dreidimensionalen Phasendiagramms der FVIII-Bindung an Mem-
branen als Funktion ihres PS-Gehalts und der Annexinkonzentration. Um die Relevanz
der Ergebnisse fu¨r die Blutgerinnung zu demonstrieren, wurden die Experimente in
Plasma wiederholt.
Da Plasma eine stark streuende Substanz und angefu¨llt mit Makromoleku¨len ist, be-
einflusst es FCS-Experimente stark. Deswegen wurde im Rahmen dieser Arbeit eine
Technik entwickelt, die FCS-Messungen in solch komplexen Substanzen erlaubt. Dazu
wurden die Einflu¨sse von Streuung und von hohen Makromoleku¨lkonzentrationen auf
FCS anhand eines Modellsystems bestehend aus GFP in hochkonzentrierten Vesikello¨-
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sungen untersucht. Es wurde gezeigt, dass Streuung den Fokus vergro¨ssert und ver-
zerrt, wa¨hrend hohe Makromoleku¨lkonzentrationen die Diffusion verlangsamen. Unter
Beru¨cksichtigung beider Effekte konnten Korrekturen erarbeitet werden, die artefaktfreie
Analyse von Bindungsmessungen in komplexen Lo¨sungen erlauben. Um FCS-Messungen
in solchen Medien und insbesondere in Zellen weiter zu verbessern, wurde zudem ein
Zwei-Photonen FCS-Mikroskop aufgebaut.
Auf dem Hintergrund dieser Ergebnisse wurden FCS-Experimente an lebenden Zellen
durchgefu¨hrt. Die effektive Viskosita¨t in Dictyostelium discoideum Zellen wurde gemes-
sen und mit Werten aus deren Lysat verglichen. Die Erho¨hung der Viskosita¨t im Zyto-
plasma konnte den hohen Konzentrationen an polydispersen Makromoleku¨len zugeschrie-
ben werden, wa¨hrend die Viskosita¨t im Aktinkortex vom polymerisierten Aktinnetzwerk
bestimmt wird. Durch Zugabe von polymerisationsregulierenden Substanzen wurde
der Polymerisationsgrad im Zytoplasma erho¨ht. Zudem wurden dadurch Aktinwellen
erzeugt, detektiert und ihre Viskosita¨t gemessen.
Ein Projekt in enger Zusammenarbeit mit den Gruppen von Prof. Bein und Prof.
Bra¨uchle konnte ein Wirkstofftra¨gersystem erfolgreich entwickeln, charakterisieren und
testen. Dabei werden mesoporo¨se Nanopartikel als Tra¨ger benutzt, die durch Lo¨sungs-
mittelaustausch mit Lipiden ummantelt werden. Dabei wurde mit FCS und Spektro-
metermessungen gezeigt, das die Lipide eine dichte Hu¨lle um die Nanopartikel bilden.
In-vivo-Studien konnten schliesslich die effektive Funktionalita¨t der lipidummantelten
Nanopartikel beweisen.
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3 Introduction
Protein-membrane interactions are of pivotal importance to biology. Since cells are en-
capsulated by membranes, all forms of communication of the cell with its environment
have to pass the membrane. Sensing and signalling processes often involve protein-
membrane interactions. Many signalling pathways for instance are triggered by binding
of certain proteins to the cellular membrane. Such protein-membrane interactions trans-
fer external signals to the interior of cells and initiate responses such as the activation of
regulatory networks leading to the expression of certain genes or other cellular processes.
A prominent example is the initiation of mitosis by EGF binding to EGF-receptors of
the cellular membrane [1]. Next to the sensing of external signals, the cell uses the mem-
brane to send signals to its environment, such as by expression of phosphatidylserine
upon apoptosis, which leads to binding of the protein annexin [2]. An other key function
of protein-membrane interactions in nature is the local confinement of processes, which
involve proteins. Blood coagulation for instance is confined to the region of the injury,
where the membranes express phosphatidylserine. Phosphatidylserine mediates binding
of FVIII and other coagulation proteins to the membranes and hence, it is on the sur-
face of the platelet membrane, that activated FVIII (FVIIIa) subsequently forms the
tenase complex with FIXa, which induces further downstream events leading to coagula-
tion [3]. Here, the crucial role of protein-membrane binding is to concentrate the tenase
complexes, limit the interactions to two dimensions and to provide optimal mutual ori-
entation of the tenase components. Severe diseases, such as cancer or bleeding disorders
in the case of coagulation, are caused by dysfunctions of certain protein-membrane inter-
actions. Considering these consequences of possible malfunctions and the importance of
protein-membrane interactions for life, it is very desirable to understand the underlying
biophysical and biological mechanisms.
A quantitative understanding of protein-membrane interactions is of importance to
systemic modeling of processes involving such interactions. Systems biology aims to
describe and simulate complex biological networks. A description by means of systems
biology of e.g. the coagulation cascade or other biological processes of similar importance
and complexity has the potential to boost medical and pharmaceutical research and
hence could drastically improve diagnostics and therapy of many diseases. Yet, the
complexity of biochemical networks represents a formidable challenge. Prerequisite for
reliable modeling is the knowledge of all binding constants, reaction rates and possibly
their dependence on various system states. To this end, lipid membrane related reactions
impose an even more complex description. In particular, membrane binding can be
strongly cooperative and be affected by the local as well as global composition of the
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membrane. The binding of EGF to membranes e.g. comes along with sequestering of the
charges of the PIP moiety in the membrane [4,5]. Hence, the lipid membrane composition
plays a regulatory role, which is not fully captured in the present day simulation tools.
This work focusses on protein-membrane interactions within the coagulation cascade,
particularly, the binding of FVIII to membranes. Investigations on PS-vesicles as model
systems for platelets showed that binding of inactivated FVIII to membranes is strongly
associated with electrostatic interactions and therefore increases with the concentration
of charge (i.e. phosphatidylserine) in the membrane [6]. For activated FVIII however,
binding and particularly, its dependence on the PS-content, has not yet been investi-
gated. Likewise, there is not yet quantitative support for regulatory processes such as
the scenario of competitive binding of FVIII and annexin as depicted in the coverfigure.
Fluorescence Correlation Spectroscopy is a powerful tool for the investigation of
protein-membrane interactions. It measures diffusion times and can discriminate freely
diffusing proteins from proteins bound to vesicles as model membranes based on the
size-dependence of the diffusion time [7, 8]. Hence, binding isotherms can be obtained
from consecutive titration experiments. Compared to other conventional techniques used
for binding experiments, such as ELISA, which all rely on one component bound to a
surface, an advantage of Fluorescence Correlation Spectroscopy is that it allows for mea-
surements in solution. However, if desired, experiments can be performed on supported
lipid bilayers as described in chapter 12. In this thesis protein-membrane binding within
coagulation was investigated with FCS using both, experiments in solution as well as on
supported membranes.
To elucidate the protein-membrane interaction of FVIII and FVIIIa as well as the
mechanism behind the influence of annexin on FVIIIa binding to membranes, the bind-
ing characteristics of FVIII and FVIIIa are studied with Fluorescence Correlation Spec-
troscopy as a function of the PS-content of the membrane. Furthermore, the regulatory
role of annexin V on FVIIIa binding is investigated and is found to be based on the
strong PS-dependence of FVIII. The results of these studies are presented in chapter
7. All of these experiments are performed in dilute buffer solutions, where Fluorescence
Correlation Spectroscopy is a well established technique. Since the natural environment
of coagulation processes is blood, it is desirable to measure in a more physiological solu-
tion compared to buffer. Blood and other biological fluids however, represent complex
media, which are scattering and crowded and hence strongly influence Fluroescence Cor-
relation Spectroscopy experiments. To overcome this challenge, a technique to measure
in complex soft matter systems was developed, which is described in chapter 6 and allows
for measurements of FVIIIa binding to membranes in plasma. Furthermore, it provides
a basis to measure in living cells and emphasizes the importance of viscosity measure-
ments. With this in the background the viscosity in living dictyostelium discoideum
cells is probed using Fluorescence Correlation Spectroscopy, as described in chapter 10.
To further improve the performance of in-vivo experiments by a reduction of scattering,
a two-photon microscope was set up (chapter 11).
All investigations layed out above are related to membranes and their biological func-
6
tion. However, membranes are also of great importance to biotechnology, e.g. as drug
delivery systems. A project of this thesis, presented in chapter 9, was the design, char-
acterization and test of a drug delivery system consisting of membrane-coated colloidal
mesoporous silica nanoparticles. Since liposomal drug delivery often employs PEGylated
vesicles, chapter 8 studies the influence of PEGylation on protein binding to liposomes.
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4 Fluorescence Correlation
Spectroscopy
4.1 Principle
Fluorescence correlation spectroscopy (FCS) measures the intensity time trace of fluores-
cent particles in the optical focus and gains information out of the intensity fluctuations.
Measurements are usually performed with a confocal setup where two pinholes are used
to guarantee for a very small, well defined focus of about 0.2 fl. Combined with a sam-
ple concentration in the nanomolar regime this enables one to have on average only a
few particles in the focus and hence it allows for a sensitive detection of small intensity
fluctuations [9]. To extract information on the fluorescent particles out of the intensity
fluctuations, FCS employs the autocorrelation of the intensity traces with respect to
time (Fig. 4.1). The normalized autocorrelation function G(τ) is defined as:
G(τ) =
〈I(t) · I(t+ τ)〉
〈I(t)〉2 (4.1)
where averaging of the intensities is usually done over 30-600 s depending on the sample.
The experimental autocorrelation function G(τ) incorporates intensity fluctuations from
various sources, which include among others photophysical effects as well as rotation
or diffusion dynamics with each appearing at a characteristic timescale [9, 10]. For
the timescales and systems, which are investigated in this thesis, the autocorrelation
functions are composed of a photophysical contribution due to triplet kinetics and a
contribution from the diffusion dynamics of the fluorescent particles:
G(τ) = 1 +Gtrip ·Gdiff (4.2)
The triplet contribution reveals the photophysical characteristics of the fluorescent dye
and its interaction with the sourrounding solution. It is usually described by an expo-
nential decay [10]:
Gtrip(τ) = (1 +
ftrip
1− ftrip )e
− τ
τtrip (4.3)
with the triplet decay time τtrip and the fraction of molecules in the triplet state ftrip.
Triplet kinetics was not subject of this work and Gtrip was only included into the fitting
9
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Figure 4.1: Principle of Fluorescence Correlation Spectroscopy: Information on
fluorescent particles is extracted from their intensity time trace via the autocorrelation
function
procedure to obtain reliable results for Gdiff . For simplicity Gtrip is therefore neglected
in the following explanations.
The contribution to the autocorrelation originating from intensity fluctuations due to
Brownian diffusion of the fluorescent particles can be analytically derived assuming a
Gaussian-shaped focus of waist ωx in-plane and ωz along the focal axis. In the case of
particles showing three-dimensional Brownian diffusion in a solution, this yields [9]:
Gdiff =
1
N
· 1
1 + τ
τD
· 1√
1 + τ
S2·τD
(4.4)
where N denotes the average number of particles in the focus and S the structure
parameter, which is the ratio between the focus radius in z- and in x-y direction, being
defined by S = ωz/ωx. The diffusion time τD provides a measure for the average time
required by a particle to cross the focal width and is given by:
τD =
ω2x
4D
(4.5)
with D being the diffusion coefficient of the fluorescent particles. The average number
of particles in the focus, N , is related to the concentration, c, of the particles in the
sample solution via the confocal Volume V :
N = c · V (4.6)
The structure parameter depends only on the optical properties of the setup and the
sample solution. Therefore, most frequently it is determined from a measurement of a
10
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(b)(a)
Figure 4.2: Illustration of binding experiments with FCS on the example of activated
FVIII binding to PS-vesicles. (a) Focus with fluorescently labeled, fast diffusing,
small proteins, which are slowed down when bound to the large unlabeled vesicles. (b)
Autocorrelation functions of activated FVIII binding to PS-vesicles. From blue to red
they are shifted towards longer times due to an increased lipid concentration leading
to an increased amount of bound proteins.
well known sample and then kept as a fix parameter unless the optical properties of the
sample solution are changed, e.g. by a change of buffer. Equation 4.4 can then be used
to analyze FCS experiments with the particle number N and the diffusion time τD as
free fit parameters. This allows for a very accurate determination of the relative size of
the concentration, the diffusion coefficient [11] and related parameters such as viscosity,
η, and hydrodynamic radius [12], R, which can be deduced from the diffusion coefficient
employing the Stokes-Einstein relation:
D =
kT
6piηR
(4.7)
To obtain absolute values, the confocal volume V has to be known. Measurement of
absolute quantities and determination of the confocal volume V will be described in
chapter 4.3. In this thesis the high accuracy of relative measurements was employed to
study for instance the effective viscosity within dictyostelium discoideum cells compared
to the viscosity in cell lysate upon drug treatment and in different parts of the cell.
4.2 Binding experiments
Another important application of the ability of FCS to measure relative diffusion co-
efficients and their changes with high accuracy is the performance of binding experi-
ments [7, 13–15]. The analysis of such binding experiments with FCS is based on the
fact that diffusion of particles depends on their size as described by equation 4.7. Fig.
11
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4.2(a) shows small fluorescent particles in the focal volume, which are diffusing freely in
solution and consequently exhibit an autocorrelation function with a fairly short diffu-
sion time. As soon as they bind to larger particles, their diffusion will be slowed down
leading to an increase of the diffusion time. The autocorrelation of a solution of bound
and unbound molecules consists of contributions from both, each weighted by their rel-
ative concentration in the solution. Hence, the decay of the autocorrelation of such a
solution is shifted towards longer times with increasing fraction of bound molecules. An
example for this change of the autocorrelation upon binding is displayed in Fig. 4.2(b),
which results from an increasing amount of labeled Factor VIIIa binding to unlabeled
vesicles.
In a system composed of multiple distinct species, the autocorrelation function can
be generalized:
G(τ) =
∑
q2iNigi(τ)
(
∑
qiNi)2
= N
∑
q2i figi(τ)
(
∑
qiNi)2
(4.8)
with the mean particle number Ni and the brightness qi of component i. fi is the frac-
tion of component i and gi represents its time-dependent autocorrelation function. This
form of the autocorrelation function allows for the analysis and discrimination of species
of different diffusion characteristics and can be applied to quantitatively determine the
binding of small fluorescent particles to particles of larger size as described above qual-
itatively. Evaluation of the relative fraction of bound and unbound particles resulting
from a two-component fit to the autocorrelation functions obtained in a titration ex-
periment yields the binding isotherm [7]. In the case of equal brightness of bound and
unbound particles, equation 4.8 can be written as:
G(τ) = 1 +
1
N
∑
figi(τ) (4.9)
with the particle number N . When particles are used, which change brightness upon
binding, e.g. due to quenching effects, this has to be considered by corrections to equa-
tion 4.9 or analysis with the general equation 4.8 [16]. The fluorescent molecules investi-
gated in this thesis did not show any change in brightness upon binding. Thus, equation
4.9 was used to analyse binding experiments.
To reduce artifacts from the fitting routine, the autocorrelation of each component,
gi, was determined separately and then kept as fixed parameter leaving the number of
particles and the fractions of bound and unbound particles as the only free fit parameters.
4.3 Quantitative analysis of absolute values
FCS is a very accurate technique to determine the relative size of concentrations and
diffusion coefficients with important applications, such as the evaluation of binding ex-
periments explained above. Additionally, it provides a means to determine the absolute
12
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values of concentration and diffusion coefficient. The parameters τD and N depend on
the optical volume. From these, the characteristic parameters of the measured sample,
namely the diffusion coefficient and the concentration, which are independent of the op-
tical setup, can be derived with equation 4.5 and 4.6. To this end, a precise knowledge
of the size of the confocal volume and hence an exact calibration is crucial [17].
In order to test the performance of absolute concentration measurements and to find
a reliable calibration method, experiments on dye solutions of known concentration were
carried out. The concentration of a 26 nM solution of Rhodamine 6G was verified pho-
tometrically. The relative concentrations of a titration experiment were successfully
measured with FCS. To extract absolute values, the common calibration procedure is
to determine the size of the confocal volume via equation 4.5 using the diffusion time
from a fit to an autocorrelation function of a reference experiment on Rhodamine so-
lution and the diffusion coefficient for Rhodamine of 280µm2s−1 as reported by Magde
et al. [18]. The obtained size of the confocal volume can then be used to calculate the
concentration according to equation 4.6. However, this method did not yield the right
concentrations. Therefore, as an alternative method, the volume was calculated via
equation 4.6 with the known concentration and the particle number revealed by the fit.
The calculated volume was then used to determine the diffusion coefficient yielding a
value of 408µm2s−1. The same experiment was done using a fluorescein calibration stan-
dard at a well defined concentration of 50 nM. Again, the common calibration with the
diffusion coefficient of Rhodamine failed to reveal the right concentration. The diffusion
coefficient of fluorescein in water deduced from calibration via the known concentration
was 430µm2s−1.
The diffusion coefficients obtained with the alternative method employing the known
concentrations agree very well with the values of Culbertson et al. [19], who measured
diffusion coefficients of 414µm2s−1 for Rhodamine and 425µm2s−1 for fluorescein in wa-
ter with microfluidic techniques. These values were confirmed recently by novel FCS
techniques such as Scanning FCS [20] and double focus FCS [21], which employ intrin-
sic well-defined length scales, i.e. the scanning speed and the distance of the two foci,
respectively, for calibration. From these findings, one can conclude, that the diffusion
coefficient reported by Magde et al. [18](with a reported error of 35%) was not accu-
rate enough and hence the commonly used calibration procedure led to wrong results
whenever this value was used.
Even with the recently determined values, calibration via the diffusion coefficient
bears some reservations and has to be applied with great care. Calibration measure-
ments should always be done under the same conditions as the experiments regarding
solvent and temperature to name just the most important factors. A change of buffer
for example might change the refractive index of the sample and this can have a strong
influence on size and shape of the confocal volume [22, 23]. Chapter 6 deals with the
influences of the surrounding medium on the performance of FCS in more detail. The dif-
fusion coefficients found in literature, which could be used as reference for calibration,
however, are usually determined in water under standard conditions. Since diffusion
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coefficients are strongly dependent on solvent and temperature, they can not be used
for calibration in solvents or under conditions different from the reference experiment.
This restriction can be circumvented by the calibration method via the concentration.
The concentration is a very well-defined parameter, independent of temperature and
solvent. It can be determined separately with independent techniques under standard
conditions or standard calibration solutions with well known concentrations can be used.
The solution can then be diluted in well-defined steps with the buffer used for the ex-
periments and calibration can be performed under the same conditions as the sample
measurements. Hence, determination of the size of the confocal volume via the concen-
tration allows for calibration adaptable to a huge variety of non-standard experimental
conditions and leads to reliable results as demonstrated by the values for the diffusion
coefficients reported above.
One further issue has to be considered for all concentration measurements, no matter
whether they are absolute or relative: The background intensity should be negligible
compared to the signal of the sample. Otherwise the influence of the background signal
has to be taken into account during analysis. In this case, the measured intensity is
composed of the sum of background and sample signal:
Imeasured = Ibackground + Isample (4.10)
This equation can be used to correct the autocorrelation function for the background
signal and simple considerations and algebraic transformations lead to a parabolic de-
pendence of the measured number of particles on the concentration of the sample:
Nmeasured = N(1 +
Isample
Ibackground
)2 = c · V (1 + Isample
Ibackground
)2 (4.11)
This dependence is shown in Fig. 4.3 which reveals the number of GFP molecules
determined experimentally as a function of the relative GFP concentration of the sample
solution. The data exhibit a parabolic shape and can be described consistently by the
red line which represents a fit according to equation 4.11. For concentrations which are
high enough to produce a signal much brighter than the background, the number of
particles increases linear with the concentration and a background correction according
to equation 4.11 is not necessary. Experiments at lower concentrations, however, need
to be corrected for the background influence to yield reliable results.
4.4 Cross-correlation
The explanations of FCS analysis in the sections above dealt with autocorrelation func-
tions, correlating only one single intensity trace with itself. Another option of FCS
analysis is to crosscorrelate two different intensity traces with each other, yielding a
cross-correlation function Gcross(τ) as follows [24]:
Gcross(τ) =
〈I1(t) · I2(t+ τ)〉
〈I1(t)〉〈I2(t)〉 (4.12)
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Figure 4.3: Experimentally determined number of GFP molecules in the focus as a
function of the relative GFP-concentration in the solution. With decreasing concen-
tration the influence of the background signal increases leading to a parabolic depen-
dence.
where I1 and I2 are the measured intensities. Cross-correlation functions of single colour
intensity traces obtained from two separate detectors during the same experiment are
often used to improve the signal to noise ratio and to eliminate noise from the detector.
Another very important application of cross-correlation analysis are dual colour exper-
iments on samples containing two different species each labeled with a fluorescent dye
of different colour [25, 26]. If the signals of the two colours are spectrally discriminated
and detected at the same time in separate channels the autocorrelation provides infor-
mation on each single species and is complemented by the cross-correlation of the two
channels yielding information on the correlation of the movement of the two species,
i.e. whether they are bound and move in a correlated way or whether they move in-
dependently. For independent movement of the species the cross-correlation constantly
equals one, whereas colocalization of the species and hence correlated movement leads
to a distinct cross-correlation function. The amplitudes of the cross-correlation and the
autocorrelation functions can then be used to deduce the fraction of colocalized particles
( [25, 26]).
4.5 Instrumentation
FCS measurements were performed on an Axiovert 200 microscope with a ConfoCor 2
unit (Carl Zeiss, Jena, Germany). Excitation was usually done with an Argon ion laser
at 488 nm, with an average power of 15µW on the sample. Fluorescence emission was
filtered from the excitation light using a 525/25 bandpass filter. The objective used was
a 40x (NA =1.2) water immersion appochromat (Carl Zeiss, Jena, Germany). Samples
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were measured in eight well LabTek I chamber slides (nunc, Rochester, NY), except
for in-vivo cell measurements, which were carried out on glass cover slides. For cross-
correlation experiments with Alexa 647-labeled molecules, a HeNe-laser (633 nm) and a
longpass 650 filter were added to the setup and the objective was replaced by a 63x (NA
= 1.2) water immersion appochromat (Carl Zeiss, Jena, Germany), which collects less
fluorescence light, but has a better correction for chromatic aberration. Correlation and
analysis were performed using the ConfoCor 2 software. Fitting procedures employing
other functions than equation 4.4 and 4.9 were carried out using Origin.
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In this chapter the analysis of titration experiments for the investigation of protein-
membrane binding is explained. FCS measurements allow for the determination of the
fraction of bound protein as a function of the lipid concentration, which can then be used
to extract the equilibrium binding constant. Here, the underlying definitions and theory
are described for equilibrium constants as well as for association and dissociation rates,
which can be accessed by time-resolved FCS experiments. Knowledge of the binding
constants and particularly their dependences on certain parameters in its turn allows for
the investigation of mechanisms of interaction, which can be very complex in the case
of protein-membrane binding. The last section of this chapter explains some of these
mechanisms and the complexity which can underlie protein-membrane binding.
5.1 Equilibrium binding constants
The reaction of a simple bimolecular binding process of a single ligand l binding to a
single receptor r leading to the formation of the complex lr, is characterized by the
stochiometric equation
l + r  lr (5.1)
This process is determined by the law of mass action. The corresponding molar partition
coefficient, also named (association) binding constant, is defined as:
Klr =
lr
lfree · rfree (5.2)
Binding measurements often reveal the fraction of bound ligands fboundl, i.e. the number
of bound ligands lbound relative to the total amount of ligands ltot = lfree + lbound:
fboundl =
lbound
ltot
=
lbound
lfree + lbound
(5.3)
In this simple case of a two-body interaction, the number of bound ligands lbound equals
the number of comlexes lr and the fraction of bound ligands can be expressed in terms
of the binding constant by insertion of equation 5.12 into equation 5.3:
fboundl =
lbound
lfree + lbound
=
lr
lfree + lr
=
K · rfree
1 +K · rfree (5.4)
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This equation can be used to experimentally determine the binding constant of a ligand
receptor interaction. A measurement of the fraction of bound ligand as a function of
the concentration of free receptors yields the so-called binding isotherm, which is an
S-shaped curve, when plotted on a semi-log scale, and can be used to extract the bindng
constant with a fit according to equation 5.4.
Measurements revealing the fraction of occupied receptors foccr, i.e. the number of
occupied receptors rocc relative to the total amount of receptors rtot = rfree + rocc:
foccr =
rfree
rtot
=
rocc
rfree + rocc
(5.5)
can be used to determine the binding constant from a titration of the ligand concentra-
tion in analogy to the case layed out above with the equation:
foccr =
K · lfree
1 +K · lfree (5.6)
The considerations above were all done assuming that a single ligand binds to a single
receptor. However, there are many biological reactions for which this assumption is inad-
equate. Often, receptors offer more than one single binding site to ligands. Sometimes,
this is accompanied by a switch-like binding behaviour resulting in clear ”on”-”off” sig-
nals. In this case of all-or-nothing binding either all binding sites n on a receptor are
occupied by ligands or none. This can be expressed by the following reaction equation:
nl + r  lnr (5.7)
The number of occupied receptors lnr can be written in terms of the binding constant
using equation 5.12 iteratively:
lnr = K
nlnr (5.8)
The fraction of receptors occupied due to all-or-nothing binding to their n binding sites
can be written as:
foccr =
lnr
rfree + lnr
(5.9)
Using equation 5.8 this can be rewritten as:
foccr =
(K · lfree)n
1 + (K · lfree)n (5.10)
Due to the cooperative all-or-nothing behaviour, the binding isotherms resulting from
this reaction are steeper compared to those of single ligand binding and this steepness
allows for clear discrimination of bound and unbound states.
From a statistical point of view the fraction of bound ligands can be interpreted as
the probability that a ligand is bound to a receptor. This allows for an easy expansion
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of the bimolecular reaction of single ligand binding as described above to the general
case of ligands binding to receptors of n binding sites. In contrast to the all-or-nothing
binding, here, one up to n ligands can bind to one receptor. Assuming that the binding
constant, K, for a ligand to a receptor is independent of the amount of occupied binding
sites on that receptor, the probability pi of a ligand binding to a receptor of n binding
sites which is occupied by i ligands is the same for all i = 0, 1, ..., n− 1. The probability
pboundl that a ligand is bound to a receptor with n possible binding sites is then given
by the sum over the probabilities pi to bind to a receptor with i occupied binding sites:
pboundl =
n−1∑
i=0
pi =
n−1∑
i=0
p = n · p (5.11)
Due to the independence of the binding probability on the amount of occupied binding
sites, the probability p can be expressed in terms of the bimolecular reaction using
equation 5.4. The fraction of bound proteins, i.e. the probability that a ligand is bound
to a receptor can thus be written as:
fboundl = pboundl = n · p = n K · rfree
1 +K · rfree (5.12)
Using a statistical descripition of binding processes the theoretical treatment can be
generalized to binding involving for instance more than one binding constant and hence
it can be adapted to various situations [27]. However, in the following binding constants
were always assumed to be equal.
In this thesis, protein-membrane binding was investigated with a membrane realized
by large unilamellar vesicles of 100 nm diameter. They act as receptor which can be
occupied by up to n proteins, i.e. ligands. Hence, the fraction of bound proteins fbound
can be expressed in terms of free vesicles Vfree using equation 5.12:
fbound = n
K · Vfree
1 +K · Vfree (5.13)
However, the binding constant described here strongly depends on the size of vesicles.
In order to obtain a general form, which is independent of the vesicles, the binding
constant is usually defined in terms of lipid concentration instead of vesicle concentration.
The binding can be treated as bimolecular reaction of protein and lipid with a binding
constant as given by equation 5.12:
K =
PL
Lfree · Pfree (5.14)
where PL is the number of bound proteins, Lfree, the number of free lipids and Pfree the
number of free proteins. The fraction of bound proteins can be directly deduced from
equation 5.4:
fbound =
K · Lfree
1 +K · Lfree (5.15)
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Since large unilamellar vesicles consist of a lipid bilayer, only half of the lipids are exposed
to the surface and accessible for binding. This is sometimes considered by defining the
binding constant in terms of accessible lipid, which differs from the total amount of lipid
by a factor of two [28].
Another way to describe binding of proteins to lipids, which is often used in literature
about protein-membrane interactions within hemostasis, assumes that i lipids form one
binding site [6, 29]. Consistently the resulting binding constant KiL is related to the
binding constant in terms of lipids, KL, by:
KiL = i
PLi
Pfree · Lfree = i ·KL (5.16)
However, the number of lipids bound per protein, i, is not experimentally accessible in
most cases. Hence, in order to obtain general results and to enhance fitting accuracy
by minimization of the number of free fit parameters, the binding constant in terms of
total lipid concentration as given by equation 5.14 is used in this thesis.
In the case that the smaller proteins are fluorescently labeled, FCS measures the frac-
tion of bound proteins with respect to the total amount of protein in the sample. Thus,
FCS measurements can be used for the determination of the fraction of bound proteins
as a function of the lipid concentration resulting in binding isotherms as described above.
From these, the binding constant K can be determined with a fit according to equation
5.15. The concentration of unbound lipids, however, is not known and has to be replaced
by the total concentration of lipids L, consisting of the unbound and bound lipids. This
yields a quadratic equation, which is solved by:
fbound =
K−1 + Ptotal + L−
√
(K−1 + Ptotal + L)2 − 4L · Ptotal
2Ptotal
(5.17)
In the case of excess lipids (i.e. L  PL), the concentration of free lipids Lfree can be
replaced by their total concentration, leading to an equation, which is much simpler as
compared to the general case [7]:
fbound =
K · L
1 +K · L (5.18)
Since this work dealt only with binding under conditions of excess lipids, equation 5.18
was exclusively used to fit binding isotherms.
To extract the fraction of proteins bound to vesicles by FCS measurements, compli-
cated corrections are sometimes applied to consider possible effects due to several labeled
proteins binding to one vesicle, which lead to an enhanced brightness of the bound com-
plex [7]. This is only necessary, when the number of bound complexes needs to be
determined. In order to measure the binding constant with equation 5.18, however, the
number of bound proteins relative to the total amount of proteins is the experimental
parameter and in this case no corrections have to be performed, since any possible effects
cancel out (if quenching upon binding is negligible as in this thesis):
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According to equation 4.8 the autocorrelation function resulting from a binding mea-
surement is given by:
G(τ) =
∑
q2iNigi(τ)
(
∑
qiNi)2
(5.19)
Assuming for simplicity that only two possible species are present, free proteins and com-
plexes of m proteins bound to one vesicle, which exhibit an m-fold enhanced brightness as
compared to the free proteins, the autocorrelation resulting from an FCS measurement
reads:
G(τ) =
∑
q2iNigi(τ)
(
∑
qiNi)2
=
Nfree
(Nfree +mNs)2
gfree +
mNs
(Nfree +mNs)2
gs (5.20)
whereNfree is the number of free proteins, Ns the number of slowly diffusing complexes of
m proteins bound to one vesicle and gfree and gs are the characteristic autocorrelation
functions of the free proteins and the complexes, respectively. The apparent number
of particles N determined from this equation by a comparison with equation 4.8 is
N = Nfree +mNs. The real number of particles is given by the number of free proteins
plus the number of complexes Nfree+Ns and is thus overestimated by the measurement.
The total number of proteins Ptot, however, consists of the sum of the number of free
proteins Nfree and the number of bound proteins mNs:
Ptot = Nfree +mNs (5.21)
Hence, it is exactly revealed by the apparent number of particles in the measurement.
The effects due to the brightness enhancement of the complex by the factor of the
number of bound proteins and the reduction of the number of detected proteins due to
the binding of n proteins to one vesicle, which are then detected as one particle, cancel
out. The same applies to the measured fraction of bound proteins fmeasured, which is
determined from a fit according to equation 5.20 to be:
fmeasured =
mNs
Nfree +mNs
(5.22)
Since mNs reveals the total amount of bound proteins and the total number of proteins
Ptot is Nfree+mNs as layed out above, the measured fraction of bound proteins fmeasured,
yields the fraction of bound proteins as used in equation 5.18 without the need of any
corrections. This case, which was restricted to two species of free protein and m proteins
bound to one vesicle, can be easily generalized to any number of species and hence, the
measured fraction of bound protein can be directly used for the determination of binding
constants with equation 5.18.
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5.2 Association and dissociation rates
Time-resolved experiments allow for the determination of the evolution of free protein
with time. The resulting data can be used to obtain the association and dissociation
rates of the binding process. For a reversible process, according to the reaction scheme
as described by equation 5.1, which is expressed in terms of protein concentration P and
lipid concentration L as follows:
P + L PL (5.23)
the association rate is given by [30]:
−dP
dt
= kass · P · Lfree − kdissPL (5.24)
If kdiss is negligible, the process can be considered as irreversible and the corresponding
expression of the temporal evolution of the concentration of free protein reads:
−dP
dt
= kass · P · Lfree (5.25)
In the case of excess lipid, this equation can be solved, yielding the time-dependent
concentration of free protein:
P (t) = Ptot · exp(−kassLt) (5.26)
where Ptot is the concentration of free protein at time zero. This equation can be used to
determine the association rate from a measurement of the concentration of free protein
as a function of time starting at the time when the reaction partners are mixed together
until equilibrium is reached.
In order to determine the dissociation constant of a reversible process, equilibrium has
to be shifted toward the left [30]. This can be achieved either in a dilution experiment
or by addition of excess unlabeled protein. The dissociation rate is then measured by
the evolution of the bound complexes with time and is given by [30]:
−dPL
dt
= kdiss · PL (5.27)
Integration yields the time-dependence of the concentration of bound complexes, which
is used to determine the dissociation rate experimentally:
PL(t) = PL0 · exp(−kdisst) (5.28)
The relation of equilibrium binding constant, association- and dissociation rate is easily
obtained from equation 5.24 to be:
K =
kass
kdiss
(5.29)
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Hence, equation 5.18 and 5.17 can be used to determine the equilibrium constant from a
titration experiment and the association and dissociation rates can be measured by time
resolved experiments with FCS employing equation 5.26 and 5.28, respectively. Since
the temporal resolution of FCS is too low to resolve diffusion-limited binding processes,
the association rate of such processes has to be calculated with equation 5.29.
5.3 Mechanisms of and influences on protein-membrane
binding
The equilibrium binding constant K as defined above is related to the binding energy
∆E by
∆E ∝ ln(K) (5.30)
Based on this relation, the binding constant, particularly its dependence on distinguished
parameters can give evidence on the properties of the binding energy and hence the un-
derlying binding mechanisms. The mechansims of protein-membrane binding are often
complex and composed of several interactions. An important mechanism in this context
is the insertion of hydrophobic protein tails into the bilayer. This is for instance ob-
served for FVIII binding to phospholipid membranes [31]. In this case the insertion of
hydrophobic parts of the protein follows a first rapid binding process mediated by electro-
static interaction, one of the most important interactions leading to protein-membrane
binding [32]. Electrostatic binding to a charged membrane can be described theoretically
employing the Poisson-Boltzmann equation. In the case of a homogeneous charge distri-
bution this yields an exponential dependence of the binding energy on the relative charge
content of the membrane [33]. Experimentally, this was shown for instance on MARCKS
peptide binding to negatively charged phosphatidylserine containing membranes [7] and
on small basic Lys peptides binding to membranes containing acidic lipids [28]. This
relation holds only for homogeneous charge distributions on the membrane. The com-
position of membranes however often varies locally and thereby imposes an additional
complexity to the binding mechanism. Binding of proteins to membranes can for exam-
ple induce demixing of the membrane or lead to an accumulation of certain lipids near
the binding site. These influences of the membrane composition on protein-membrane
interactions play an important role for the regulation of such processes and were found
in many biological systems. This kind of regulation by spatial organization is for exam-
ple found for the polyvalent acidic lipid phosphatidylinositol 4,5-bisphosphate (PIP2),
which is sequestered by membrane-adsorbed basic peptides due to electrostatic interac-
tions [4,5]. Another example is the formation of microdomains on the plasma membrane
of T cells induced by membrane-bound protein-protein networks that exclude or trap
signaling molecules [34].
In addition to spatial organization, coating of the membrane can have a significant
influence on its interaction with proteins. Polymer coatings, for instance, are used to
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create a steric barrier which acts as repulsive mechanism and thereby protects the lipid
bilayer from close approach of proteins and other macromolecules [35].
These were some, but by far not all cases of the interaction of membranes and their
composition with protein-membrane binding. However, not only the membrane, but
also the protein conformation plays an important role for protein-membrane binding.
Some proteins have to be activated to be able to bind to membranes. Annexin B12,
for instance, needs to assume a membrane-competent formation before it binds to phos-
pholipid membranes [36]. Other proteins, such as amyloid-β undergo conformational
changes, which are induced by their insertion into a membrane [37].
All the parameters and scenarios layed out above influence the binding constant and
might lead to remarkable binding behaviours which might be challenging to investigate.
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FCS is a well established technique for measurements in dilute solutions, its performance
in complex fluids remains, however, a challenge since scattering and hydrodynamic ef-
fects due to crowding strongly influence the experiments. In the context of this thesis, it
was desirable to measure in plasma, the natural environment of blood coagulation, and
in highly concentrated vesicle solutions, which both are complex media. The challenge
is to separate the influences of the medium, which might lead to artifacts [22], from
the measurement to allow for reliable data analysis. Once this is achieved, FCS experi-
ments can be performed in any complex medium, thereby enabling measurements under
biologically relevant conditions. Here, FCS is performed in highly concentrated vesicle
solutions, which represent a well-defined crowded model system, to investigate the par-
ticular corrections related to scattering and hydrodynamic effects. The results show,
that both, scattering as well as the decrease in diffusion constant due to crowding, can
be quantitatively described consistently with theory. The corrections derived from these
findings are applied to measure the binding isotherm of annexin V to PS-vesicles in a
highly concentrated PEGylated vesicle solution yielding the same binding constant as in
buffer and hence, verifying the corrections. Furthermore, consequences of these findings
for calibration and measurements in blood plasma and in living cells are discussed. The
results of this chapter are published in [38].
6.1 Complex media
In the following chapters several FCS experiments, which were performed in complex
media, will be presented. To measure in the natural surrounding of blood coagulation
and thereby prove the relevance of the results of FVIII binding to membranes (chap-
ter 7), measurements were carried out in blood plasma. Blood plasma, however, is a
strongly scattering, crowded fluid. Due to the low binding the experiments on annexin
binding to PEGylated vesicles described in chapter 8 had to be performed at very high
vesicle concentrations which lead to scattering (Fig. 6.1) and hydrodynamic effects.
Likewise, the molecular environment of many other biological systems is highly concen-
trated and heterogeneous and thus profoundly more complex than solutions of purified
components in vitro. Twenty to thirty percent of the intracellular space is occupied
by globular protein, fibrils or lipid membranes, a fact, that is described by the term
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(a) (b) (c)
Figure 6.1: (a) Autocorrelation of eGFP in buffer () and in 25% volume fraction
vesicles (O). Inset: comparison of the normalized autocorrelation. (b) Illustration of
the illumination profile in a concentrated vesicle solution. Solid lines represent the
focus in buffer solution, while dashed lines represent the distorted focus resulting from
scattering. eGFP molecules in the focal volume are excited and their intensities can
be detected. Buffer and concentrated vesicle solution (25%) are shown in (c).
macromolecular crowding [39–41]. In recent yeears many biophysical implications of
crowding have been investigated. It has become evident that the space filling properties
of cellular components significantly alter the dynamic viscosity of the solution [42–44].
The reduced mobilities have an immediate consequence on reaction rates and transport
properties. Moreover, excluded volume can have an immediate effect on equilibrium
constants. In particular, binding can be affected solely by the surrounding colloidal
solution or by some of its components, as is the case for annexin regulation of FVIIIa
binding in plasma, which is shown in chapter 7 to be much more efficient as compared
to buffer solution [39, 45]. Therefore, it would be desirable to measure protein binding
in its natural environment, which may be the intracellular space, tissue or plasma in
the case of the coagulation factors investigated in this thesis. Protein interactions are
likewise of technical importance in complex fluids such as microemulsions, creams or
pharmaceutical products. In all cases, complex soft matter systems with high volume
fractions of material, that adopt a mesoscopic internal structure, are considered. As a
consequence of these properties, these solutions are often optically turbid making analy-
sis by optical techniques optimized for measurements in dilute buffer solutions difficult.
Moving to natural solutions bears experimental challenges; for instance, cells and plasma
scatter light resulting in both enhanced background and obscured signals. Consequently,
caveats regarding quantitative evaluation and calibration apply and careful validation is
required in each particular case.
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6.2 Scattering effects
In order to investigate the influence of complex media on the measurements, FCS ex-
periments on eGFP in buffer and in concentrated solutions of PEGylated vesicles were
compared. PEGylated vesicles were chosen to form an inert, well-defined and tunable
crowded medium and eGFP served as inert and bright fluorescent tracer molecule. The
vesicles were obtained from Bayer Health Care and were confirmed to be monodisperse
and of a radius of 45 nm. Fig. 6.1 (a) shows an autocorrelation curve of eGFP in
buffer and the autocorrelation of eGFP in concentrated vesicle solution. With increas-
ing vesicle concentration, the amplitude, G(0), of the autocorrelation curve decreases,
while at the same time the diffusion time increases (as seen from the insert which dis-
plays the normalized autocorrelation curves). These effects are due to scattering and
hydrodynamic slowdown as will be discussed later. The amplitude G(0) of the eGFP
autocorrelation function and hence, the apparent size of the effective confocal volume,
was noted to become unusually sensitive to the focal depth when measured in vesicle
solutions. As schematically shown in Fig. 6.2(a), this is due to scattering, which distorts
the focal volume with increasing length of the light path through the crowded medium.
A measurement of the relative change of the focal width ωx(z)/ωx0 and height ωz(z)/ωz0
as a function of focal depth is displayed in Fig. 6.2(c). To analyse the autocorrelation
functions of these measurements, equation 4.4 was rewritten using the concentration
c = N/V , the diffusion coefficient D according to equation 4.5 and the Gaussian focal
volume V = pi1.5ω2xωz:
Gdiff =
1
c · pi1.5ω2xωz
· 1
1 + 4Dτ
ω2x
· 1√
1 + 4Dτ
ω2z
(6.1)
In this equation, the fit parameters can be separated into those dependent on the
solution only and those dependent on the optical setup. Parameters, like the diffusion
time or the average particle number in the focus, which link the characteristics of the
solution with the optical parameters, are eliminated. In the measurements investigating
the focal volume as a function of the focal depth, concentration and diffusion coefficient
of the solution are constant and well known, since they are independent on the focal
depth. Hence, they can be used as fixed parameters and equation 6.1 allows for the
direct determination of the focal width and height, particularly, their variations in these
experiments.
Comparison of the two curves in Fig. 6.2 (c) obtained from two-parameter fits accord-
ing to equation 6.1 to the measured autocorrelation curves reveals a two-fold change in
focal height ωz whereas broadening in the x-direction is limited to about 10%. A control
experiment in buffer did not show any dependence on the focal depth over the whole
range of distances used for the experiments in vesicle solution.
To further investigate the nature of scattering in concentrated vesicle solutions, the
transportation mean free path in the vesicle solutions was measured using coherent
27
6 Diffusion measurements in crowded, scattering media
(c) (d)
(b)
(a)
z
Figure 6.2: (a) Schematic diagram of the distortion of the focus as a function of the
length of the light path (focal depth) through the scattering medium. (b) Broadening
of the focus profile in x- (O) and z- (•) direction as obtained from simulations. (c)
Width (H) and height (•) of the focus as a function of focal distance to the chamber
surface determined from a fit according to equation 6.1. (d) Number of particles
and structure parameter S increase significantly as the distance of the focus from the
chamber slide surface increases.
backscattering experiments. Here, the sample was illuminated by a laser beam and the
scattered intensity in the backward direction was detected. The cone of the coherently
backscattered light is a measure of the transportation mean free path [46, 47]. In the
vesicle solutions, the transportation mean free path was much longer (> 5mm) than the
path of light in the sample (∼ 200µm). From that one can conlude that the scattering
process is in the single scattering regime and isotropic multiple scattering can be excluded
[46]. As a consequence, scattering is not necessarily isotropic. As we are dealing with
spheres of 100 nm size compared to several hundred nm wavelength, most of the light
is scattered in forward and backward direction [47]. Simulations written in Matlab
confirm the findings from FCS analysis, that scattering from 100 nm spheres elongates
the focus along the beam direction. Data obtained from these simulations are shown
in Fig. 6.2(b) and provide a qualitative proof that broadening of the focus due to
scattering is much stronger along beam direction than perpendicular to it. Simulations
are written assuming that all photons are focussed on one spot and during their path in
the scattering medium they are scattered with a probability depending on the density of
vesicles. Vesicles are distributed on a grid and photons, which pass a grid point occupied
by a vesicle, are scattered. The scattering angle and hence, the new propagation direction
of the photon is determined from the scattering profile of spheres as described in Meller
et al. [48].
As shown in Fig. 6.2(d), the anisotropic scattering leads to a drastic increase in the
S-Parameter S with increasing focal depth and has to be taken into account for all
measurements in scattering media. As S usually is determined once in a calibration
measurement and then fixed for all following experiments, the increase in S has immedi-
ate consequences on the calibration procedure. However, due to the independence of the
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(a) (b)
Figure 6.3: (a) Relative increase in number of particles in the confocal volume
plotted against the volume fraction of vesicles for eGFP (◦) and antibodies (N). (b)
Semi-log plot of the relative change of diffusion coefficient as a function of the volume
fraction of vesicles. The line represents an exponential fit
scattering effects (and hence the increase of S) from the tracer molecule, calibration can
be done separately in each scattering medium with a standard tracer molecule, such as
eGFP. The curves in Fig. 6.2 also show, that from 250µm there is a saturation regime,
where slight variations in the focus position do not influence its shape and size notice-
ably. In this thesis, all experiments in complex media were performed in this regime to
obtain stable results.
As a next step, the evolution of the confocal volume at fixed focal depth but with
increasing vesicle volume fraction was investigated. The data were obtained by fitting
equation 4.4 with free fit parameters N , S, and τD. Due to scattering the number of
particles in the focal volume increases with increasing vesicle concentration. Fig 6.3(a)
shows the increase in the apparent number of chromophores in the focal volume starting
at a volume fraction of about 7% and then increasing steadily with volume fraction.
Data were acquired using eGFP and fluorescently labeled antibodies as tracer molecules.
Both data sets exhibit the same behavior. Consequently, the apparent number effect is
independent of the tracer molecule which was expected since the effect occurs from the
distortion of the focal volume due to scattering.
6.3 Hydrodynamic slowdown
The diffusion coefficient, as determined from these measurements using equation 4.5,
decreases significantly with increasing vesicle concentration. This remarkable slowdown
is not an artifact due to focal broadening, but rather due to crowding. Fig. 6.3(b) shows
the change of diffusion coefficients D relative to the value in buffer, D0, as a function of
the vesicle concentration. The semi-log plot reveals an exponential dependence of D/D0
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on the volume concentration of vesicles:
D/D0 = exp(− φ
φc
) (6.2)
with the critical volume fraction φc fitted to be 0.35. This result is consistent with the
exponential dependence as found in many crowded systems. The change of the effective
viscosity in a colloidal suspension was first described by Einstein [49]. For crowding
agent concentrations studied here, hard sphere models of diffusion employing scaled
particle theory [50,51] and Brownian dynamics simulations [52] predict exponential de-
pendencies. The experimental results presented here, serve as an elegant confirmation of
these predictions. Additionally, they agree very well with measurements in soft matter
systems such as Ficoll 70 [53] and micelle solutions [54], as well as those in biological sys-
tems, such as hemoglobin in red blood cells [55]. Consequently, concentrated liposome
solutions qualitatively exhibit the expected crowding behavior. Within experimental
errors, the diffusion coefficients are also consistent with the rigorous theory of diffusion
in hard sphere colloidal suspensions [50,51].
For FCS experiments in crowded media, this change of the diffusion coefficient bears
important consequences, since the diffusion coefficient cannot be used for calibration in
the usual manner. Furthermore, when the diffusion time is used to determine interac-
tions in a crowded medium, the hydrodynamic slowdown needs to be distinguished from
specific changes of the diffusion constant due to reactions such as binding to macro-
molecules or vesicles.
6.4 Consequences for applications
6.4.1 Calibration
Since any scattering medium or any medium having a refractive index different from
water changes the focal volume with respect to the standard volume in water, calibra-
tion is one of the major challenges when it comes to performing FCS measurements
in soft matter [22, 23]. To overcome this issue, other groups have developed new FCS
techniques where an additional length scale introduces a robust intrinsic calibration,
as already shortly mentioned in chapter 4.3. Dual focus FCS [56], for instance, uses
the distance of the two foci for calibration, while scanning FCS [57–59] is calibrated
via the scanning velocity. Another option used with increasing frequency, especially for
measurements in cells, is two-photon FCS, where scattering is strongly reduced due to
the long excitation wavelengths [60]. The experiments described above show that even
without these techniques, reliable results can be achieved by considering the fact that
the distortion of the focal volume due to scattering is independent of the tracer molecule
and can thus be determined separately in an appropriate calibration measurement. This
allows for the introduction of reliable calibration in scattering media.
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6.4.2 Binding experiments
A particular interest within the context of this thesis are binding experiments in complex
media. The performance of FCS binding experiments in such media was tested with
the specific binding of annexin V to PS-vesicles in a solution of 25% vol PEGylated
vesicles. As discussed in chapters 7 and 8, annexin V binds specifically to PS-lipids in
a calcium-dependent manner, but does not show any specific binding to POPC-vesicles.
The challenge is to separate the FCS signal changes due to scattering and crowding from
changes resulting from binding events. FCS experiments were performed as a function of
increasing concentrations of PS vesicles in solutions with fixed amounts of Alexa-labeled
annexin in both, pure citrate buffer as well as a crowded PEG-liposome solution, each
with calcium added in a concentration of 50 mM. The fractions of free proteins, ffree,
and proteins bound to PS vesicles, fbound, were determined according to equation 4.9,
making use of the fact that the diffusion constant of free and vesicle-bound annexin
differs by about a factor of 10.
Data evaluation was done for all data sets as follows: to achieve reliable fitting results
for the fraction bound in a two-component analysis, the diffusion time of free protein
and the structure parameter were fixed. As described above, it is important to consider
the fact that the diffusion times, as well as the structure parameter vary with the volume
fraction of the vesicle medium. The corrections for the scattering effect and slowdown
due to crowding could be taken directly from Fig. 6.3(a) and (b) as determined from
the GFP test experiments. The structure parameter at a certain vesicle concentration
can then be calculated using equation 4.6 and the value of the particle number at that
vesicle concentration taken from Fig. 6.3(a). The diffusion time at a certain vesicle
concentration can be determined using equation 4.5 and the corresponding diffusion
constant shown in Fig. 6.3(b). However, this way of making the corrections is based on
the assumptions that the change of the focal volume in x- direction due to scattering is
negligible and that the investigated molecule is as inert as GFP in the crowded medium.
The later is not the case for annexin V, for instance, which shows weak unspecific bind-
ing to PEGylated vesicles as described in chapter 8. Alternatively, the diffusion time
and structure parameter for Alexa-labeled annexin in PEGylated vesicles can be directly
measured in the crowded medium. Here, this was done by measuring annexin diffusion
in a PS-free PEGylated vesicle solution. The structure parameter and diffusion time
were determined from this measurement using equation 4.4 and then kept fixed for the
succeeding analysis of experiments with increasing fraction of charged vesicles. Using
equation 4.9, the fraction of free and bound annexin was determined. A typical two-
component curve of annexin binding to PS-vesicles in highly concentrated PEGylated
vesicle solution is shown in Fig. 6.4(a), and the resulting binding curve is shown in
Fig. 6.4(b). Following the FCS experiment of annexin binding in highly concentrated
vesicle solutions with increasing amount of PS-vesicles measurements were carried out
in buffer. The binding curve determined in buffer and in concentrated PEGylated vesi-
cle suspension match well. The use of corrected diffusion constants for FCS data in
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(a) (b)
Figure 6.4: (a) Measured autocorrelation curve of annexin binding to PS-vesicles
in highly concentrated PEGylated vesicle solution (◦) and the corresponding fit curve.
Residuals are shown below. (b) Fraction of annexin bound to PS-vesicles as a func-
tion of the PS-vesicle concentration measured in buffer solution () and in highly-
concentrated PEGylated vesicle solutions (◦). Uncorrected data in highly-concentrated
PEGylated vesicle solutions (4) lead to an overestimation of binding.
crowded medium for both the free and bound annexin is critical as shown by the dashed
line which indicates the outcome of the analysis without correction. Hence, binding mea-
surements in highly concentrated vesicle solutions can be carried out if the optical, as
well as hydrodynamic influences of the crowded medium, are taken into account. These
findings allow for FCS measurements of dynamics and molecular interaction in turbid
and crowded media. Thus, these results provide a basis for measuring and analyzing
colloidal solutions used for pharmaceutical and cosmetic applications as well as in food
industry.
6.4.3 Blood plasma
The results of the investigation of the FCS performance in complex media also allows for
experiments in blood plasma. Plasma is a yellow, strongly scattering fluid, crowded with
macromolecules such as for example coagulation factors. Using Alexa-labeled antibody
as fluorescenct tracer molecule, the S-parameter in plasma was measured to be enhanced
by a factor of 3 as compared to buffer solution. The slowdown of diffusion due to
crowding in plasma was determined for tracer molecules of different size as shown in
Fig. 6.5. For all tracer molecules, diffusion was slowed down by a factor of 1.8, which
is even more than the slowdown at the highest concentration of PEGylated vesicles
of 0.25% vol. Hence, the corrections for binding experiments as described above for
annexin are even more important. Interestingly, the slowdown does not depend on the
size of the tracer molecule in this range of sizes, whereas Dix et al. [43] report a strong
size dependence of the slowdown for DNA. However, this difference might be due to the
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Figure 6.5: Diffusion time of several tracer molecules in buffer as a function of
their diffusion time in plasma. The solid line represents a linear fit, revealing an
enhancement of diffusion time in plasma by a factor of 1.8 as compared to buffer.
Comparison with the dashed bisecting line shows the deviation of the values in plasma
from those in buffer.
shape of DNA and the big range of sizes they investigated.
As shown in chapter 7, binding in plasma could be successfully measured with these
corrections. This demonstrates that FCS is a powerful tool for performing binding
assays under physiological conditions, which is a very promising feature for applications
in research and diagnostics.
6.4.4 Cell experiments
Another application of FCS in scattering, crowded media, are in-vivo experiments in
cells. In scattering media, a strong increase in the distortion of the focal illumination
volume with increasing light path in the medium was found until saturation is reached.
This allows one to conclude that experiments on the surface of the cover slip, as peformed
when making measurements in living cells growing on the surface of the cover slip, are
less influenced by scattering than measurements in an equally-scattering soft matter
system in solution, which is typically investigated at a standard focal distance of 200µm
above the cover slip surface. However, measurements at the surface have to be performed
at a very stable focus height, since they are more sensitive to small deviations in focus
height as compared to measurements performed in saturation regime.
Eucaryotic cells are reported to be composed of up to 30% volume fraction liposomes
[39–41]. Based on this value, the value of φc = 0.35 reported above suggests that
the hydrodynamic slowdown due to crowding reduces the diffusion coefficient in cells
by a factor of 2. Given that the ratio of the diffusion coefficient of GFP in water to
that in living eucaryotic cells has been reported to be 3-4 [40], the results which only
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take into account hydrodynamic slowdown in crowded solutions of hard spheres do not
explain the reduction completely. Additional effects, such as binding of GFP to cellular
components or hydrodynamic slowdown due to diffusion in actin networks, which reduce
diffusion much more than soluble spherical macromolecules [61], might cause this further
reduction of the diffusion constant. No indication of anomalous diffusion was seen in the
model liposome system. For diffusion in eucaryotic cells, however, there are controversial
discussions on anomalous diffusion. While some authors report anomalous exponents
between 0.8 and 0.9, others do not see anomalous behavior [43]. The results of the vesicle
model system indicates that liposomal crowding alone will not account for anomalous
diffusion. However, a polymerized actin network or a solution of polydisperse crowding
agents could induce subdiffusive behavior.
Based on these findings, the chosen model system of concentrated vesicle solutions,
which permit to distinguish between influences due to scattering and hydrodynamic
effects and facilitate the control of the influence of crowding via changes in vesicle con-
centration, provides a good basis for studies on crowding in cells. Furthermore, the
results on the influence of scattering and crowding on the performance of FCS experi-
ments allow for reliable FCS measurements in living cells.
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7 Membrane-binding of Factor VIII
within blood coagulation
7.1 FVIII binding to membranes
7.1.1 Hemostasis
Hemostasis is a complex mechanism of the circulatory system that prevents the body
from bleedings. The hemostatic process, which takes place upon an injury, can be
split into two major steps. First, thrombocytes adhere with the glycoprotein-complex
GPIb/IX acting as a receptor to subendothelial collagen in a reaction mediated by van
Willebrand Factor. In a second step, this thrombocyte matrix is stabilized by a dense
fibrin network. The establishment of this fibrin network is product of a complex sys-
tem of interactions of coagulation factors and is called blood coagulation cascade (Fig.
7.1) [62]. This cascade consists of two pathways, an extravascular and an intravascu-
lar pathway, which both lead to the activation of the proenzyme Factor X. In its turn,
Factor X together with FVa builds an enzyme-complex leading to the conversion of pro-
thrombin into thrombin. Thrombin, which is the key enzyme of the coagulation cascade,
activates fibrinogen and thereby enables it to build a stable polymer network. Activation
of Factor X via the extravascular pathway is done by a complex of membrane-activated
Factor VII, membrane-bound tissue factor and calcium. The intravascular pathway in-
volves activated FVIII (FVIIIa) and FIX building the membrane-bound tenase-complex,
which then activates factor X. In this step, the formation of the tenase complex confines
blood coagulation to the surface of the membrane, which is of great importance, since
it concentrates the tenase complexes, provides optimal mutual orientation of the tenase
components and limits coagulation to the injured tissue. The intravascular pathway
works 50-fold more efficiently than the extravascular pathway. Consequently, a dysfunc-
tion within the intravascular pathway leads to severe bleeding disorders. Hemophilia A,
probably well known through its occurence in the British Royal family, is one example
of such diseases [63]. In this case, deficiency of Factor VIII blocks the intravascular
pathway and hence severe bleedings can not be stopped.
7.1.2 Structure, activation and catabolism of FVIII
As described in the previous paragraph, FVIII is a key protein of the coagulation cascade
and its deficiency leads to severe bleeding disorders. Being a 330 kDa glycoprotein of 2332
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Figure 7.1: Schematic drawing of the reaction network of the coagulation cascade.
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Figure 7.2: Molecular structure of FVIII. (a) Domains of FVIII. The protein is
activated through cleavage by thrombin, which removes the B-domain. (b) Structure
of membrane-bound FVIII as reconstructed from electron chrystalography data [31].
amino acid residues, FVIII consists of three homologous A-domains, two homologous C-
domains and one B-domain, which are ordered as follows: A1-A2-B-A3-C1-C2 (Fig.
7.2) [3]. Released into the circulatory system, FVIII immediately forms a complex with
van Willebrand factor. This tight binding to van Willebrand factor prevents FVIII
from building the tenase-complex with Factor IX and protects FVIII from inactivation
by protein C, FIXa and FXa. The van Willebrand factor binding sites on FVIII are
located at the C1, C2 and the A3 domain (at its part next to the B-domain) [64].
Activation of FVIII is done mainly by thrombin through cleavage of the B-domain (Fig.
7.2), which coincides with a conformational change of the C2-domain [65]. This cleavage
removes the protecting van Willebrand factor and hence allows activated FVIII (FVIIIa)
to interact with FIXa and thereby leads to the formation of the tenase-complex. The
catabolism of FVIII has been found to be mediated by low-density lipoprotein receptor-
related protein (LPR) and heparan sulphate proteoglycans (HSPGs), one of the major
glycoprotein components of the extracellular matrix. According to the model suggested
for the FVIII catabolism, initial binding of the FVIII/van Willebrand factor complex
to the cell membrane occurs mainly via interaction with HSPGs. Bound to the cell
surface, FVIII is either taken up by LPR mediated endocytosis or by LPR independent
endocytosis, which is possibly mediated directly by the HSPGs, whereas van Willebrand
Factor does not enter the endocytotic pathway [65].
7.1.3 Labeling of FVIII via antibodies
Binding measurements using FCS as presented in this and the following chapters provide
a great potential for applications in research, diagnostics and quality control of e.g.
pharmaceutical, cosmetical or food products. For all these applications a quick, easy
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Figure 7.3: Fluorescent labeling via antibodies: fluorescently labeled antibodies (a)
bind to the protein (b) and can be used to investigate binding of the protein to unlabeled
vesicles (c) with FCS. (d) Schematic drawing of FVIII binding to a phospholipid
membrane and the antibodies used for labeling in this study attached to it.
method, which avoids direct chemical modifications, is desirable. Elaborate extraction
of the proteins and resuspension after labeling could strongly influence the sample and
change its binding behaviour. Furthermore, directly labeled proteins tend to aggregate
and hence disturb the performance of FCS experiments. To use a labeling method, which
meets the criteria listed above, FVIII was labeled via fluorescently labeled antibodies.
Antibodies are fluorescently labeled and added to a solution containing FVIII. They
bind to FVIII and thereby fluorescently label the protein (Fig. 7.3). This method
reduced aggregation of FVIII and allowed for indirect, easy labeling. Moreover, possible
functional sites of the protein, which are involved in binding, can be explored by antibody
mapping, which employs different antibodies that each bind specifically to one sequence
of a certain domain of the protein. Antibodies, which inhibit binding, bind to possible
candidates of the binding site of the protein.
Antibodies were fluorescently labeled with Alexa 488 using an antibody-labeling kit
(Invitrogen). After labeling, the antibody-solution contained a huge amount of free dye
molecules and a non-negligible number of aggregates. Aggregates were filtered out with
a membrane-spin column (Vivaspin 500, Sartorius). Free dye was eliminated by centrifu-
gation in a Bio-spin column (Bio-Spin 30, Bio-Rad). After this purification process, a
control experiment with FCS was performed to check whether any free dye or aggregates
were left. In the case of the detection of any impurities in the sample, purification with
the respective columns was repeated. After successful labeling, antibodies were used
at a concentration of approximately 10 nM as fluorescent markers for FVIII. Various
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antibodies binding to different sites of the FVIII molecule were tested (Fig. 7.3(d)) and
for each experiment the most appropriate one was chosen. ESH4, for example inhibits
binding of FVIII to PS-membranes, since it binds to the membrane binding site of FVIII.
Hence, it could not be applied for measurements on this binding.
7.1.4 FVIII interaction with phospholipid membranes
Formation of the tenase-complex can only occur when activated FVIII is bound to the
phospholipid membrane of platelets. Consequently, binding of (activated) FVIII to phos-
pholipid membranes is a key process of blood coagulation. Studies employing resonance
energy transfer techniques have shown that negatively charged phosphatidylserine (PS)
is required for binding with a minimum amount of three PS-molecules per bound FVIII
molecule [6]. For the binding mechanism of inactivated FVIII a two-step process was
suggested consisting of a first rapid binding process, which is mediated by electrostatic
interaction and represents the main regulatory step of FVIII binding, and a second
slower binding step, the mechanism of which was suggested to be insertion of hydropho-
bic protein domains into the membrane [32]. These findings were confirmed by electron
crystalography studies on the 3D-structure of membrane-bound FVIII, which is shown in
Fig. 7.2(b) [31]. According to these studies the height of the protein above the membrane
is 9.5 nm. Part of the C2-domain is buried into the lipid bilayer (up to 1 nm in depth)
and the overall C2 binding area covers 7 -10 nm2. The C2-domain exhibits 4 hydropho-
bic loops inserted into the membrane and 3 lysine residues, which are close enough to
the membrane for electrostatic interaction with the charged PS-lipids. Hence, the first
step of binding could be mediated via electrostatic interaction of the lysine residues and
the charged lipids and the second step via insertion of the hydrophobic loops. In this
thesis FCS was used to further elucidate the protein-membrane interaction of FVIII
and to investigate the binding of FVIII to PS-containing vesicles as model membranes.
FVIII was labeled via fluorescent ESH2 antibodies, which bind to the C2-domain of
FVIII without obstructing its capability to bind to PS-containing membranes [66], as
described in the previous paragraph. Likewise ESH8 and C7F7 could be used, which
bind to the C2- and A3-domain, respectively and were tested to yield the same results.
Since the large unilamellar vesicles (100 nm in size) used were sufficiently large to allow
for discrimination of the diffusion times of bound and unbound FVIII, binding was mea-
sured with FCS employing the method layed out in chapter 4.2. The fraction of bound
proteins was extracted from the measured correlation function with appropriate fits as
described in chapter 4.2. Titration experiments yielded the fraction of bound protein as
a function of the lipid concentration (see Fig. 7.4). These isotherms were recorded for
lipid compositions with varying amount of PS. In each case S-shaped binding isotherms
were found, which were described by equation 5.18 with a PS-dependent molar partition
coefficient K(PS):
fbound =
K(PS) · L
1 +K(PS) · L (7.1)
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(a) (b)
Figure 7.4: FVIII binding to PS-containing membranes. (a) Binding isotherm ob-
tained from a titration experiment on FVIII binding to vesicles of 10% PS-content.
(b) Molar partition coefficient of FVIII binding to vesicles as a function of their PS-
content. The measured data (•) are in excellent agreement with the data of Gilbert
et al. (O) [6]. The line represents an exponential fit.
where L is the molar lipid concentration in solution. The molar partition coefficient
K(PS) describes the distribution of free and bound FVIII and hence its binding affinity or
binding constant to the lipid membrane. Naturally K(PS) is a function of the relative PS-
content of the membrane. The dependence of FVIII binding to membranes on their PS-
content is plotted on a semi-log scale in Fig. 7.4. The molar partition coefficient increases
with increasing strength of binding, showing that FVIII binding increases continuously
with increasing PS-content of the membrane. The line represents a fit indicating an
exponential increase within the range of PS-contents studied. This exponential increase
of FVIII binding to membranes with increasing PS-content (i.e. charge of the membrane)
can be explained in terms of electrostatic interaction. In a first simplified model one
can assume that electrostatic binding energy is proportional to charge and the binding
energy is proportional to the logarithm of the molar partition coefficient. Thus the
molar partition coefficient should increase exponentially with charge. More elaborate
theoretical models on electrostatic membrane interactions involving Poisson-Boltzmann
theory, also predict an exponential dependence of electrostatic binding on the charge
of the membrane [28, 67]. Hence, these findings confirm the assumption of a binding
mechanism based on electrostatic interaction of FVIII and PS-containing membranes,
as suggested from the experiments by Bardelle et al. [32] and Stoylova-McPhie et al. [31].
Comparison of the results with molar partition coefficients calculated from the data of
Gilbert et al. shows very good agreement (Fig. 7.4) [6]. This consistency also serves as a
proof for the excellent ability of FCS to measure binding of such systems. Furthermore,
the data for membranes with a physiological PS-content of about 10% compare very well
with data obtained for binding to platelets [68], which shows that the PS-membranes
are good model systems for platelets.
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(a) (b)
Figure 7.5: Binding isotherms of FVIIIa binding to vesicles at different PS-content
(black 7%, red 10%, blue 15%, green 30%). The best binding can be observed at 10%.
(b) The molar partition coefficient of activated FVIII binding to membranes (H) peaks
at around 12% relative PS-content and is very sensitive to the PS-content around the
physiological PS-content of about 10%PS (marked in red) and at PS-concentrations
between 12 and 15% (marked in grey). In contrast, the molar partition coefficient of
inactivated FVIII (2) increases continuously with increasing membrane PS-content.
The anomaly in FVIIIa binding is measured using ESH2 (H) as well as ESH8 (◦) as
label
7.2 Activated FVIII interaction with phospholipid
membranes
So far, studies on the binding of FVIII to membranes were focussed on inactivated FVIII.
Little is known on the mechanism of activated FVIII binding to membranes. However,
in blood coagulation, binding of activated FVIII to membranes is crucial for the forma-
tion of the tenase-complex, since inactivated FVIII is not able to react with FIX and
to trigger further downstream events in the cascade. Therefore, FVIII was activated by
incubation with human thrombin at 37 ◦C for 30 min prior to the experiments and its
binding to membranes was investigated here. To gain further insight into the binding
mechanism of FVIIIa to membranes, the molar partition coefficient was measured as a
function of the relative PS-content of the membrane yielding for the first time the full PS-
dependence of FVIIIa binding to phospholipid membranes. Binding experiments were
carried out using the FCS-method, which proved to yield reliable results for inactivated
FVIII binding to membranes. Again, S-shaped binding isotherms were obtained from
titration measurements (Fig. 7.5(a)), which were described by equation 7.1. The mea-
sured molar partition coefficient K(PS) as a function of the PS-concentration is shown
in Fig. 7.5(b). Whereas binding of inactivated FVIII to membranes increases continu-
ously with increasing PS-content of the membrane, binding of activated FVIII deviates
remarkably from this behaviour. Fig. 7.5(b) shows a strongly peaked dependence of
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FVIIIa binding on the PS-content of the membrane. The binding sharply increases up
to K(PS)=0.6µM−1 at a relative PS-concentration of 12%, which exceeds the binding of
non-activated FVIII by 100%. Surprisingly, beyond this point, the binding constant of
activated FVIII decreases again and reaches a minimum at about 17% PS-content. This
behaviour must be considered anomalous, since the general understanding requires at
least the electrostatic interaction to increase with PS-content. To exclude any influences
of the antibody labeling, which could induce conformational changes of the protein or
change its binding behaviour via other interaction pathways and thereby lead to such
an anomalous binding behaviour, experiments were repeated with different antibodies.
First, ESH2 was replaced by fluorescently labeled ESH8, an antibody which binds to
a sequence on the C2-domain (in this case the van Willebrand factor binding site) dif-
ferent from that of ESH2. Fig. 7.5(b) shows, that both ESH2 and ESH8 lead to the
same remarkable anomaly in binding to PS-membranes. As a negative control, exper-
iments using fluorescently labeled ESH4 were performed. ESH4 is known to bind to
the membrane binding site on the C2-domain of FVIII and thus inhibits FVIII binding
to membranes (see Fig. 7.3(d)). Indeed, when ESH4 was used as label, no binding to
membranes could be detected, neither of inactivated nor of activated FVIII. Based on
these negative and positive control experiments one can conclude that the anomalous
PS-dependence of FVIIIa binding to membranes is not induced by the antibody label-
ing. Interestingly, a fourth antibody, named C7F7, which binds to the A3-domain of
FVIII, did not obstruct the capability of inactivated FVIII to bind to PS-containing
membranes, whereas it inhibited binding of activated FVIII to membranes completely.
This inhibition behaviour might be explained by a conformational change or sterical
hindrance upon binding of C7F7 to FVIIIa, which does not occur, when it binds to
inactivated FVIII. The origin of the anomalous binding behaviour is not yet fully un-
derstood. Upon activation by thrombin, the B-domain of FVIII is removed and the
protein undergoes conformational changes. Considering the change in inhibition behav-
ior of C7F7 upon activation of FVIII, these conformational changes could be believed
to induce the enhanced affinity of FVIIIa to membranes of about 12% PS-content.
It is remarkable that the anomaly of FVIIIa binding to membranes falls into the
physiological range of PS-content of platelets. In fact, comparing the molar partition
coefficients of inactivated and activated FVIII we find that activated FVIII shows weaker
binding than inactivated FVIII over most of the PS-content range, except for the narrow
region of the peak between 9 and 13%. The finding, that compared to inactivated FVIII,
FVIIIa binds stronger in the physiological range is consistent with results obtained
for binding to platelets [29]. The observed anomaly of the PS-dependence of FVIIIa
binding to membranes, however, has not been reported before. The enhancement of
binding upon the activation of FVIII around physiological conditions and the reduction
of binding upon FVIII activation at PS-concentrations lower or higher than those under
physiological conditions is important since it allows for selective enhancement of FVIII
binding, and thus, cascade amplification in case of injury. Another consequence of this
finding is reduced binding and coagulation in the absence of an injury representing a
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(a) (b)
Figure 7.6: (a) Structure of annexin [69]. The top side attaches to the membrane
upon binding. (b) Fraction of annexin bound to vesicles containing 10% PS as a
function of the calcium concentration at constant lipid concentration of 15µM .
method of thrombosis prevention, since PS is expressed only in the case of an injury,
otherwise the membranes do not contain PS, except for the case of apoptosis, where
much more PS is exhibited as compared to the concentration on injured endothel.
The sharply peaked anomaly leads to a tremendous sensitivity of FVIIIa binding to
membranes on slight changes of their PS-content in the region of the peak. Since the
physiological PS-concentrations can be found on the slope of the peak, variations of the
PS-content of platelets have a strong impact on coagulation. This fact provides a basis
for very efficient regulation of the coagulation cascade via the membrane charges. The
sensitivity of coagulation on the PS-content of the membranes might be very important
for diseases and their treatment. On the one hand, a dysfunction in the expression of PS
leading to enhanced or reduced PS-concentrations has immediate effects on coagulation.
On the other hand, coagulation can be regulated via the membrane charges mediated
e.g. by PS-binding cofactors, which might allow for treatment of certain coagulation
diseases.
7.3 Regulation of activated FVIII binding to
phospholipid membranes by annexin V
7.3.1 Annexin V binding to phospholipid membranes
In the human circulatory system, binding of FVIII to platelets is influenced by many
cofactors. One important cofactor is annexin V, a protein that binds to PS-containing
membranes in a calcium-dependent manner [36,69,70]. Fig. 7.6(b) shows the strong de-
pendence of annexin binding to membranes on the calcium concentration of the solution,
measured in this thesis. The fraction of bound annexin determined in an FCS-experiment
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(a) (b)
Figure 7.7: (a) Binding isotherm of annexin V binding to vesicles of 10% PS-
content. (b) Dissociation of annexin binding to vesicles of 10% PS-content upon
addition of unlabeled annexin in excess. The line represents an exponential fit.
with labeled annexin V increases with increasing calcium concentration leading to an S-
shaped curve. Tait et al. [71] investigated this behaviour in detail and found cooperative
effects. FCS experiments on fluorescently labeled annexin allowed for the measurement
of binding isotherms and the determination of molar partition coefficients at various
calcium concentrations. An example of such a binding isotherm obtained for 34 nM an-
nexin in 50 mM citrate buffer upon addition of 50 mM calcium is shown in Fig. 7.7 (a).
At this calcium concentration the resulting molar partition coefficient was 0.5 µM−1.
Time resolved FCS measurements upon addition of excess unlabeled annexin to labeled
annexin binding in equilibrium allowed for the determination of the dissociation rate as
described in chapter 5.2. Fig. 7.7(b) shows the resulting curve yielding a dissociation
rate of 4.6 ms−1. The association rate is too fast to be resolved by FCS experiments.
However, knowing dissociation rate and molar partition coefficient it can be calculated
using equation 5.29 to be 2.3 mM−1s−1. Assuming a diffusion limited association rate
and the vesicles to be black binders (i.e. each annexin molecule meeting a vesicle faces
only free binding sites; occupied binding sites do not exist), the association rate can be
estimated [27]:
kass =
4piDa
N
(7.2)
where D is the diffusion coefficient of annexin, a the radius of the vesicles and N the
number of binding sites per vesicle. The radius of the vesicles is known to be 45 nm, the
diffusion coefficient of annexin was determined in a separate FCS experiment on annexin
in buffer to be 70 µm2s−1. Measurements of the number of particles in the focal volume
at various fractions of bound annexin yield a rough estimate of the number of binding
sites per vesicle N , in this case N=15. Based on these values, the association rate in
the diffusion limit was calculated with equation 7.2 to be 1.6 nM−1s−1. Note that this
is the association rate in terms of vesicles and to obtain the rate in terms of lipids, it
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Figure 7.8: Scenario of FVIII, which is activated by thrombin, binding to a phos-
pholipid membrane and the regulatory influence of annexin V on it. This is the part
of blood coagulation, which was focus of this study.
has to be divided by the number of lipids per vesicle n=120000, yielding a rate of 13
mM−1s−1. Considering the simplicity of this model, the estimated association rate is
in very good agreement with that calculated from the dissociation rate and the molar
partition coefficient. Hence, one can assume the association of annexin to be a diffusion
limited process as suggested by [72].
Due to its ability to bind to PS-containing membranes, annexin V could act as a regula-
tory protein for FVIIIa binding to membranes. Indeed, annexin was shown to play a role
in coagulation through binding to endothelial cells leading to immediate consequences
on thrombin formation [73]. It was reported that antiphospholipid antibodies inhibit
annexin V binding to phospholipids, accelerating plasma coagulation [74]. Furthermore,
an inhibitory effect of annexin V on FVIII binding to platelets was found, which seems
to be specific to activated FVIIIa and not significant for inactivated FVIII [68]. Many
additional evidences for the anticoagulant effect of annexin V have been reported [70].
The mechansim of the anticoagulant effect still remains not well understood [70]. It was
proposed that formation of a two-dimensional annexin V crystal lattice leads to a reduc-
tion of lateral movement of membrane-bound coagulation factors and hence a reduction
of the kinetic rates in the membrane-based coagulation pathway [75]. Alternatively, an-
nexin is supposed to compete with coagulation factors for binding sites on the platelet
membrane, thereby inhibiting their membrane based interaction as schematically de-
picted in Fig. 7.8. The following sections present investigations, which contribute to a
better understanding of this mechanism of the effect of annexin on coagulation.
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7.3.2 Annexin V regulates FVIII binding to phospholipid membranes
To study the effect of annexin V on the binding of FVIII to membranes the vesicles were
incubated with annexin V prior to the binding experiments with FVIII. In the case of
non-activated FVIII annexin V had a weak but by trend decreasing influence on the
binding. In contrast, binding of FVIIIa was strongly influenced even at concentrations
as low as 4 µM of annexin. In fact, the full binding diagram as a function of both PS-
content and annexin concentration revealed a complex behaviour as shown in Fig. 7.9(a).
It is found that addition of annexin can both reduce as well as increase the binding of
FVIIIa depending on the PS-content of the membrane. The binding of FVIIIa to vesicles
containing 10% PS is continuously reduced by increasing annexin concentration up to
full inhibition (Fig. 7.9(b)). When vesicles of a relative PS-content of 15% were used, the
results deviated from these inhibition characteristics. Here, preincubation of the vesicles
with annexin enhances binding up to a maximum value. At concentrations higher than
this maximum, a reduction of FVIIIa binding to the vesicles is observed again (Fig.
7.9(c)).
Ahmad et al. have shown by binding experiments of FVIII and FVIIIa on activated
platelets, that annexin V inhibits binding of FVIIIa but has no significant influence on
the binding of FVIII in the absence of other cofactors. This finding is in good agreement
with the results presented here for the binding to membranes containing a physiological
concentration of 10% PS, where a continuously decreasing binding was measured with
increasing annexin V concentration.
To understand the full inhibition behaviour of annexin V, an extended inhibition model
was developed, which describes the unusual binding characteristics as found for annexin
and FVIIIa binding to phosopholipid membranes. The ordinary model of competitive
inhibition, which is usually used to describe the interaction of two species, both binding
to a third species, assumes a competition for binding sites. This competition for free
binding sites is based on mass action and the key parameter is the absolute number
of free binding sites. In the scenario of this study, binding of annexin reduces the
absolute number of available binding sites for FVIIIa leading to an effectively reduced
lipid concentration, Leff (A) = L−LA with L being the total number of lipids and LA the
number of lipids occupied by annexin. Under the assumption that annexin binds much
stronger to membranes than FVIIIa, LA can be calculated for each annexin concentration
with equation 5.17 knowing the binding constant of annexin from a separate experiment.
Plugging Leff (A) into equation 5.18 instead of L yields the fraction bound of FVIII for
competitive inhibition:
fbound =
K · Leff (A)
1 +K · Leff (A) (7.3)
This model, however, fails to describe the strong inhibition measured for membranes
of 10% PS content quantitatively as seen in Fig. 7.9(b), where the blue dashed line
represents a fit according to the model of competitive inhibition. Furthermore, it can
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Figure 7.9: (a) 3D-plot of the measured fraction of membrane-bound FVIIIa as
a function of PS-content and annexin V concentration. Influence of annexin V on
FVIIIa binding to PS membranes at a PS-content of 10% (b) and 15% (c). The blue
dashed lines indicate a fit according to competitive inhibition behavior, while the red
full lines represent a fit describing the shielding model. (d) Three-dimensional plot
showing shielding model simulations of the PS-content and annexin concentration
dependence of FVIIIa binding to membranes at a constant lipid concentration. Note
the change of axes as compared to (a). The red lines in (a) can be found following
the corresponding black lines in (d) parallel to the annexin concentration axis.
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only explain the decrease in binding, but not the enhanced binding that was found
for membranes with 15% PS content (see Fig. 7.9(c)). Therefore, the competitive
inhibition model was extended based on the fact that annexin specifically binds to PS
and modifies the relative PS concentration and hence the binding constant K(PS) by
effective ”shielding” of the PS-content. The resulting effective PS content was assumed
to be described by PSeff (A) = PS0 · (1−αAb), where the amount of bound annexin Ab
can be derived explicitely with equation 5.17 knowing the binding constant of annexin
from a separate experiment. Here, the molar shielding efficiency, α, was introduced to
quantify the efficiency of the reduction of the relative PS-content per mole annexin. A
shielding efficiency of α = 0.1µM−1 for instance implies that 1 µM annexin reduces the
relative PS-content by 10%. Due to the unusual sensitivity of FVIIIa binding to the
PS-content of membranes, as described above, a reduction of the relative PS-content
induces dramatic changes of the binding constant K(PS) causing both enhanced or
reduced binding of FVIIIa. A quantitative descripition of the fraction of bound FVIIIa
as a function of annexin concentration is given by:
fbound(PS,A) =
K(PSeff (A)) · Leff (A)
1 +K(PSeff (A)) · Leff (A) (7.4)
Note that equation 7.4 contains only one unknown parameter, since K(PS) can be
extracted from the measured data by a phenomenological fit and the amount of annexin
can be determined with equation 5.17 using a binding constant obtained in a separate
experiment. Hence, the only unknown parameter is the shielding efficiency α. Equation
7.4 describes the measured dependence of the fraction of bound FVIIIa on the annexin
concentration with very good agreement as shown by the full lines in Fig. 7.9(b) and (c).
Due to the fact that only one adjustable parameter, the shielding efficiency α, entered the
model, it is very remarkable, that both data sets, for 10% as well as 15% PS are equally
well described. To further elaborate the full phase diagram of the binding behaviour,
the theoretical landscape of binding as a function of PS and annexin concentration at a
constant lipid concentration is plotted in Fig. 7.9(d). The anomaly of the PS-dependence
of FVIIIa binding to membranes allows for inhibition and enhancement of binding, which
occurs upon reduction of the effective PS-content through the addition of annexin. The
shielding model is thus able to qualitatively and quantitatively explain the mechanism
of interaction of annexin and FVIIIa binding to membranes.
A key component of the inhibition model is the assumption that there is no direct in-
teraction between annexin and FVIIIa. All interference of annexin occurs indirectly via
shielding PS and hence modulation of the binding affinity of the membrane to FVIIIa.
In order to test this hypothesis dual color cross-correlation experiments were performed
on supported membranes as schematically depicted in Fig. 7.10(a). In this experiment
FVIIIa is labeled with green fluorescent antibody while annexin is labeled with a red
fluorescent dye. A proof of principle of such experiments on supported lipid bilayers is
presented in chapter 12 on the example of DNA diffusion on lipid membranes. Here,
fluorescence cross-correlation spectroscopy was used to distinguish single proteins from
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(a) (b)
Figure 7.10: (a) Schematic view of FCS measurements of FVIIIa and annexin V
diffusion on a supported lipid bilayer (b) Autocorrelation curves of activated FVIII
(red) and annexin (green) on a supported lipid bilayer. No cross-correlation (black)
between annexin and activated FVIII can be detected, indicating the absence of di-
rect interaction between these. The diffusion coefficient of activated FVIII is not
influenced by annexin and is measured to be approximately 10µm2s−1 for both.
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correlated protein clusters. Distinct autocorrelation curves are obtained for both, an-
nexin as well as FVIIIa, yielding a diffusion coefficient of about 10µm2s−1 for both
proteins, which is approximately equal to the diffusion coefficient of lipids in the mem-
brane (Fig. 7.10(b)). Yet, the cross-correlation shows a flat time dependence indicating
that there is no correlated diffusion of annexin and FVIIIa. Comparison with the dif-
fusion coefficients of each protein moving on membranes in the presence and absence of
the other indicated that the diffusion of one is not influenced by the other.
The results of the cross-correlation studies verify the assumptions of the shielding
model. Hence, all findings presented in this chapter support the suggestion that shield-
ing of charges, which reduces the effective charge of the membrane for FVIIIa is the
mechanism how annexin V is involved in blood coagulation. A comparison of the quan-
titative fits from the shielding model with those from competitive inhibition (full red and
dashed blue lines, respectively in Fig. 7.9(b) and (c)) demonstrates the efficiency of the
shielding mechanism in annexin-mediated regulation of FVIIIa binding even under con-
ditions where there are excess lipids, as the case was in the experiments presented here.
In contrast, competitive inhibition hardly shows any significant effect. The full three-
dimensional phase diagram calculated on the basis of the shielding model shows that
the shielding mechanism is able to explain the anticoagulant effect of annexin under
non-pathological conditions, and indicates a possible procoagulant effect for platelets
overexpressing PS to levels exceeding 12%. Based on the strong effect of annexin on
coagulation, it has a great potential as a coagulation regulating drug.
7.4 Experiments in blood plasma
To see, if the experimental results of this chapter are valid under in vivo conditions,
the experiments were repeated in FVIII deficient blood plasma. Plasma is a strongly
scattering, crowded medium, which poses an experimental hurdle to FCS measurements
that needs to be considered in the analysis as explained in detail in chapter 6 [38]. Taking
these effects into account, allowed for the measurement of FVIII binding to vesicles in
plasma. The first satisfying finding is that the molar partition coefficients of FVIII and
FVIIIa binding to vesicles in plasma in the absence of annexin are consistent with those
obtained in buffer solution. Secondly, preincubation of the membranes with annexin
V in plasma leads to the same characteristic enhancement and inhibition behaviour
as observed in buffer. Surprisingly, however, the absolute concentrations of annexin
necessary to reach the same level of inhibition differ in plasma and buffer by about a
factor of 4. This is demonstrated by rescaling the theoretical prediction for the data in
buffer (solid line) by a factor of 4 (dashed line) in Fig. 7.11. This enhancement of the
effect of annexin on FVIIIa binding in plasma could be explained by the influence of other
cofactors, such as Factor IX. Ahmad et al. [68] reported an enhanced effect of annexin
on FVIIIa binding to platelets in the presence of EGR-FIXa and FX, which supports
the suggestion of an enhancement due to the influence of other cofactors. These findings
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Figure 7.11: Regulation of FVIIIa binding to a membrane of 15% PS-content by
annexin in buffer (◦) and in plasma (H). The full line represents a fit according to
the shielding model, the dashed line is the same curve rescaled by a factor of 4 in the
x-axis.
emphasize the importance of measurements under biological conditions for investigating
processes as complex as this and encourage to further investigate these effects in both,
buffer and plasma. Since FCS allows for binding measurements in both, buffer and
plasma, it provides a powerful tool in research and diagnostics.
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8 Binding of coagulation proteins to
PEGylated vesicles
The previous chapter dealt with specific binding of coagulation proteins, namely FVIII
and annexin to membranes. Here, their unspecific binding to PEGylated vesicles is
investigated. This chapter introduces PEGylated vesicles as promising drug delivery
systems and describes the equilibrium binding constants as well as kinetic aspects of
annexin V binding to PEGylated vesicles.
8.1 PEGylated vesicles as drug delivery systems
Liposomes show a vast potential as drug delivery systems. Encapsulation of drugs into
liposomes allows them to act as carriers, which efficiently deliver drugs. They are taken
up by cells, e.g. by endocytosis or vesicle fusion and hence are able to directly deposit
their drug load into the cell [76]. Composed of a lipid bilayer they are biocompatible
and do not bear any hazards to the body, since their construction is inspired by nature,
particularly, the cell membrane. Their size and the dose of drug load can be tuned and
the lipid bilayer can be functionalized. Functionalization with proteins such as EGF,
for instance, allows for specific targeting to cells expressing the corresponding receptors.
However, one demanding challenge for the use of liposomes as drug delivery systems
remains their fairly short circulation time. Once they entered the circulation they are
recognized as foreign bodies by the immune system and quickly cleared away. Their
recognition and clearance is believed to be the result of fast opsonization of the lipo-
somes by blood proteins [77]. To this end, polymer-coated liposomes provide a solution.
Their circulation time has been shown to be tremendously prolonged as compared to
uncoated liposomes [78]. Since the polymer-layer seems to greatly reduce the clearance
of the liposomes and since they appear invisible to the immune system of the body, they
are also called stealth liposomes. Another name given to them is sterically stabilized
liposomes due to the attribution of this effect to steric stabilization. Most approaches to
explain the mechanism of this prolongation of the circulation time involve a decreased
binding of plasma proteins on the surface of the polymer-coated liposomes [77]. A promi-
nent and very promising representative of such polymer-coated liposomes are PEGylated
liposomes. In order to study their interaction with the membrane-binding plasma pro-
teins FVIII and annexin V FCS experiments on equilibrium binding as well as kinetics
were performed in this thesis. The investigation of the binding of FVIII to PEGylated
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(a) (b)
Figure 8.1: Annexin V binding to PEGylated vesicles. (a) Binding isotherm of an-
nexin upon addition of 50 mM calcium. (b) Fraction of annexin bound to PEGylated
vesicles at a lipid concentration of 0.1 M as a function of the PEG-content of the
vesicles.
vesicles is of particular interest to pharmaceutical industry since Baru et al. reported
on a prolonged circulation time and haemostatic efficacy of FVIII due to its binding to
these vesicles [79]. With this finding in the background the interaction of FVIII with
PEGylated vesicles was investigated in this thesis in colaboration with Bayer Health
Care and Bayer Technology Services. The results are summarized in an internal report
to Bayer.
8.2 Equilibrium binding constants
Titration experiments were carried out for annexin V binding to PEGylated vesicles of
100 nm diameter, which were composed of 97% POPC and 3% DSPE-PEG2000. The
resulting binding isotherm is shown in Fig. 8.1(a), revealing weak, unspecific binding.
As in the case of specific binding to PS-membranes, annexin V shows no binding without
calcium. Upon addition of 50 mM calcium, binding up to a fraction of more than 50%
bound annexin V could be measured, which allows for a determination of the binding
constant using equation 5.18. The resulting value for the binding constant K is 10 M−1,
a factor of 50000 less than binding to vesicles containing 10% PS. Fig. 8.2 illustrates the
values of the binding constants compared to those involving PS-membranes of 10% PS
content. Binding to PEGylated vesicles is unspecific and orders of magnitude weaker
than that to PS-membranes.
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Figure 8.2: Comparison of the molar partition coefficients of annexin and FVIII
binding to 10% PS vesicles and of annexin binding to 3% PEG vesicles.
8.3 Effect of PEGylation regime on binding
In order to gain more insight into the influence of the PEG-coating on binding of proteins
to stealth liposomes, the fraction of annexin bound to liposomes was recorded for PEG-
coatings of varying PEG-concentration. Fig. 8.1(b) shows the fraction of annexin bound
to PEGylated liposomes (PEG2000) at a concentration of 0.1 M as a function of their
relative PEG-content. The amount of bound annexin shows a fairly flat dependence
up to a PEG-content of 5%, where it sharply decreases to a fraction of about 20%
bound protein, which again does not change significantly within the range of measured
concentrations. The drastic decrease in binding at 5% PEG-content can be explained by
the PEG-conformation on the liposome. At PEG-contents below 5%, the polymers are
in mushroom conformation, whereas above, they assume brush conformation [80]. In
the latter conformation displacement of PEG-molecules by annexin affords more energy
than in the mushroom regime, hence, binding of annexin to liposomes coated with PEG-
molecules in brush conformation is reduced compared to those with PEG in mushroom
conformation. Comparison with a measurement of annexin binding to uncoated POPC-
liposomes shows that PEG-coating in the mushroom regime has hardly any effect on
annexin binding. From these findings one can conclude, that PEGylation of liposomes
at a concentration in the brush-regime prevents the liposomes from opsonization (at
least by annexin) and hence could prolong their circulation time.
8.4 Binding kinetics
Experiments on binding kinetics could help to further understand the mechanism of the
influence of PEGylation on the binding of proteins to liposomes. Binding of annexin to
PEGylated liposomes (3% PEG) was in equilibrium within 10 s. Thus, association rates
could not be resolved with FCS. To measure the dissociation rate unlabeled annexin
was added in excess to a solution of annexin binding in equilibrium to 0.1 M PEG-
liposomes at a fraction of 50%. Interestingly, whereas this method lead to a decrease
of binding of annexin to PS-vesicles as shown in Fig. 7.7, in the case of PEGylated
vesicles, the fraction of bound annexin did not change at all. Upon addition of EDTA,
which chelates calcium and hence inhibits the calcium-mediated binding of annexin [81],
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complete inhibition is reached within seconds (i.e. faster than FCS can temporally
resolve). These findings might be explained by a reduction of the free energy in addition
to the binding energy, which could be due to the displacement of the PEG-molecules.
This could lead to a quasi-irreversible binding as observed in the experiments above.
Upon disruption of the binding by EDTA, the annexin molecules are trapped only by
the polymer-coating and not bound. Thus, they need to cross the energy barrier of the
PEG-displacement only, which allows them to detach from the vesicles.
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nanoparticles as drug delivery system
In chapter 8, the enormous potential of liposomes as drug delivery systems was pointed
out. Here, lipid bilayers are used to coat colloidal mesoporous silica nanoparticles (CMS),
thereby combining the advantages of liposomal drug delivery, as described in chapter 8
and those of CMS, which allow for various routes of surface functionalization and control
over their size at the nanometer length scale. The lipid-coated CMS are characterized
using fluorescence cross-correlation spectroscopy which gives evidence of their structure
and monodispersity. The lipid bilayer is shown to serve as an intact barrier against the
escape of encapsulated molecules with an unsurpassed 100% sealing capacity. As a proof
of principle for their ability to deliver and release drugs, the lipid-coated nanoparticles
are loaded with the anticancer drug colchicine and efficient uptake by liver cancer cells
resulting in cell death by depolymerization of microtubules is observed. Finally, the
drug administration assisted by lipid-coated CMS is shown to be specific to intracellular
release of colchicine from the nanoparticles and hence enhances the drug efficiency. This
enhancement of drug efficiency compared to diluted drugs in solution has immediate
consequences on treatments such as chemotherapy, since it allows for delivery of concen-
trated doses into the cells and a reduction of the overall dosis given to the patient. The
project presented in this chapter was done in close colaboration with Valentina Cauda
(group of Prof. Dr. T. Bein), who synthesized and characterized the nanoparticles and
did most of the in-vitro delivery experiments, Delphine Arcizet (group of Prof. Dr. J.
Ra¨dler), who carried out the confocal microscopy experiments on the particles together
with myself, and with Anna Sauer (group of Prof. Dr. C. Bra¨uchle), who performed the
in-vivo colchicine delivery experiments.
9.1 Nanoparticles as drug delivery systems
Nanoparticles show a vast potential for medical applications as intelligent drug delivery
systems. Furthermore, they can be used as nanoagents for medical imaging and in-situ
diagnostics. Mesoporous silica nanoparticles are candidates of particular interest due
to their ability to efficiently and specifically encapsulate guest molecules [82]. Their
large surface area (between 800 and 1200 m2/g) and pore volume (about 1 cm3/g)
and their uniform pore diameter (about 4 nm), combined with accessible nanoscale
morphologies and high stability in colloidal suspensions [83] all point to their potential
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as powerful drug carriers. Moreover, their surface can be functionalized and their size
is controlable at the nanometer length scale, hence, they can be perfectly adapted to
various conditions of drug delivery. A challenge in the current development, however, is
the design of a controlled cap to prevent uncontrolled and premature release of the drug
from the mesopores. Efficient molecular pore sealing systems based on large molecules,
clusters or molecular assemblies are promising ideas for a solution to that challenge
[84–86]. Such a cap system should also fulfill more specific functions, such as a stimuli-
responsive delivery, biocompatibility and the option to incorporate specific receptors for
cell targeting. One design, which meets these criteria and employs lipid self-assembly,
is to coat the mesoporous nanoparticles with supported lipid bilayers, which mimicks
a biological cell envelop and offers several advantages [87–89]. First, the membrane
manifold prolongs circulation time and enhances accumulation in tumor cells as shown
for liposome-based delivery of doxorubicin [90]. Moreover, the high biocompatibility,
low toxicity and immunogenicity of the lipid bilayer would allow for future use in cancer
therapy. The uptake and specific targeting can be easily improved by attaching specific
receptors such as EGF or GE11 to functional groups of the lipids. Finally, compared to
liposomes, nanoparticle supported membranes should exhibit more structural stability
and a well controlled size distribution [91].
Among the main issues still faced with drug treatment are short circulation times and
low target specificity, which both decrease the efficiency of the drug and increase side
effects because larger doses are needed. In principle, mesoporous nanoparticles can retain
and protect the guest molecules before reaching the target cells, thus minimizing their
toxicity and maximizing the drug effectiveness, if an intact lipid bilayer is deposited on
the surface. Brinker and coworkers showed that lipid coating of silica can be achieved by
fusion with negatively charged liposomes followed by incubation with positively charged
liposomes [88]. The protocol yielded 100 nm lipid coated mesoporous nanoparticles
capable of retaining 75% of the loaded dye [87]. The encapsulation of even smaller
nanoparticles in a lipid bilayer was reported for fluorescent quantum dots of about 50 nm
in diameter and silica nanoparticles of 20 nm using reverse-phase evaporation methods
[92]. However, in this case, the authors found at least three quantum dots encapsulated
inside a single lipid vesicle, due to the difference in size between the quantum dots
and the liposomes (300 nm) and the approach used for their incorporation. Hence, the
preparation of intact supported bilayers on single mesoporous nanoparticles for long-term
encapsulation of a drug load and controlled release after delivery is still a demanding
issue.
9.2 Lipid-coating of the nanoparticles
In this project we used a solvent-exchange method to coat single mesoporous silica
nanoparticles with a defect-free, intact supported lipid bilayer. The principle of this
solvent-exchange method relies on the fact that lipids dissolved in ethanolic solution
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prevail as monomers, whereas they self-assemble into solid surface-supported bilayers or
liposomes as the water content of the solution is increased toward 100%. Three types
of lipid compositions were used for the lipid coatings: 100% DOPC, 100% POPC and a
mixture of 30% vol positively charged DOTAP and 70% vol DOPC (Fig. 9.1(d)). Lipids
were mixed in chloroform, then desiccated and finally dispersed in a mixture of 60%
water and 40% ethanol (Fig. 9.1(a)). Both, the CMS nanoparticles and some of the lipids
were labeled with the fluorescent dyes, Atto 647 and Bodipy, respectively, for subsequent
characterization and delivery experiments. By suspending the CMS nanoparticles in the
lipid solution, a supporting surface is offered for lipid bilayer formation upon water
addition to the solvent (up to 95% vol), thus allowing a direct and efficient coverage of
the silica surface (Fig. 9.1(c)).
Synthesis of the CMS nanoparticles and their labeling with fluorescent dyes is de-
scribed in [83,93] and yielded spherically shaped nanoparticles of a size of 50 nm with a
worm-like mesoporous structure, as confirmed by Transmission electron microscopy and
X-ray diffraction patterns (Fig. 9.2).
9.3 Characterization of the lipid coated nanoparticles
The effective self assembly of the supported lipid bilayers on single CMS nanoparti-
cles was confirmed by several characterization techniques. First, fluorescence cross-
correlation spectroscopy is used to prove, that the lipid bilayer is indeed tightly bound
to the mesoporous nanoparticle. Fig. 9.3(a) shows the autocorrelation curves of the
Atto 647-labeled CMS nanoparticles and the Bodipy-labeled lipid coating. Both curves
reveal diffusion characteristics resulting from monodisperse particles of about 60 nm
diameter. The results of both channels are in agreement, suggesting colocalization of
CMS nanoparticles and lipids. This coupling is further confirmed by analysis of the
cross-correlation function, which exhibits a distinct curve. Since contributions of cross-
talk are measured to be negligible, this curve is due to correlated movement of the CMS
nanoparticles and the lipids. Hence, it demonstrates the successful lipid coating of the
CMS nanoparticles.
The colloidal stability of the lipid-coated CMS nanoparticles was confirmed with dy-
namic light scattering. The results showed that the lipids do not only form a tight
bilayer around the nanoparticles but also sterically stabilize the nanoparticles, thereby
preventing them from aggregation.
With fluorescence microscopy, Atto 647-labeled nanoparticles (red) and Bodipy-labeled
POPC lipids (green) were visualized in separate channels (Fig. 9.3(b)). The optical
resolution is of course not high enough to allow for resolution of a single lipid-coated
nanoparticle. But it visually shows the colocalization of the two dyes, thus confirming
the encapsulation of CMS nanoparticles into the lipid bilayer.
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Figure 9.1: Scheme of the synthetic procedure of the formation of supported lipid
bilayers on colloidal mesoporous silica nanoparticles (CMS). (a) After the synthesis
of outer surface amino-functionalized CMS the amino-propyl groups are fluorescently
labeled in water. The labeled particles are then centrifuged. (b) The lipids in chlo-
roform are mixed with dye-labeled lipids. After chloroform evaporation, the mixture
of unlabeled and labeled lipids is desiccated and redispersed in a mixture of 40% vol
EtOH/60% vol water. (c) The lipid solution is added to the centrifuged dye-labeled
CMS nanoparticles. Upon addition of water, the lipid bilayer forms on the surface
of the CMS nanoparticles. (d) The three kinds of lipids used: DOPC, POPC and
DOTAP (used in a mixture of 30% vol DOTAP and 70% vol DOPC).
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Figure 9.2: Characterization results of the mesoporous silica nanoparticles. Scan-
ning Transmission Electron Microscopy (a) and X-ray diffraction pattern (b) yield
the monodispersity and wormlike mesoporous structure of the spherically shaped sil-
ica particles as well as their size of 50 nm.
, ,
, ,
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Figure 9.3: Characterization results of the lipid-coated CMS nanoparticles (a) Flu-
orescence Cross-correlation Spectroscopy of DOTAP/DOPC-coated CMS nanoparti-
cles. The nanoparticles are labeled with Atto 647, the lipids with Bodipy. (b) Fluores-
cence microscopy image of POPC-coated CMS nanoparticles. Left: Atto 647-labeled
CMS (red), middle: Bodipy-labeled POPC lipids (green), right: merged channels (yel-
low indicates co-localization of CMS and lipids). The results of both, cross-correlation
as well as microscopy, confirm the successful assembly of the lipids around the CMS.
61
9 Lipid-coated mesoporous nanoparticles as drug delivery system
9.4 In-vitro release experiments
In-vitro release experiments were performed to demonstrate that the lipid bilayer formed
on each CMS nanoparticle is compact and defect-free and that it prevents any prema-
ture release of the guest molecules from the mesostructure of the nanoparticles. To
this end, fluorescent dyes (fluorescein and calcein, respectively) were encapsulated into
the mesopores of the nanoparticles which were then capped with a lipid bilayer. The
dye-loaded and membrane-coated nanoparticles were confined in a tube sealed by a dial-
ysis membrane, which is placed on top of a fluorescence cuvette filled with water (Fig.
9.4(b)). The dialysis membrane allows only the dye molecules to enter the cuvette vol-
ume. Consequently, the monitored fluorescence emission results only from the released
guest molecules. No fluorescence is detected, when successfully coated nanoparticles are
measured. For comparison, the release of fluorescein from uncoated CMS nanoparti-
cles is shown in Fig. 9.4(a). While this reference sample exhibits a 100% release of
the absorbed guest molecules within 10 minutes, no release can be detected from the
lipid-coated nanoparticles. After one hour of monitoring without any increase in the
fluorescence emission, a membrane disrupting agent, such as ethanol or the surfactant
triton X-100, was added into the tube containing the lipid-coated nanoparticles. The
fluorescence intensity shows a rapid increase in intensity due to the prompt release of the
dye molecules from the mesoporous particles. The final fluorescence intensity of both,
the reference sample and the lysed lipid-coated nanoparticles are similar (Fig. 9.4(b)).
The release rate displayed by the lipid-coated nanoparticles after lysis appears slower
than that of the uncoated nanoparticles. This effect can be attributed to hindered diffu-
sion due to lysed lipid fragments around the nanoparticles. All three lipid compositions
and both guest molecules, fluorescein as well as the larger calcein, yielded similiar re-
sults. Hence, they all show the unprecedented efficiency in capping the mesopores of
the lipid-coating via solvent exchange leading to zero premature release of the absorbed
molecules.
9.5 In-vivo delivery and release experiments
The in-vitro experiments prompted the potential use of the lipid-coated CMS nanoparti-
cles as drug delivery system. Here, the in-vivo applicability is tested by visualization of
delivery and release of the anti-cancer drug colchicine into HuH7 liver cancer cells [94].
Colchicine binds to tubuline and thus inhibits microtubule polymerization, which leads
to cell death. After loading the drug into the CMS mesopores, the nanoparticles were
coated with a lipid bilayer consisting of POPC lipids. The supernatant with dissolved
colchicine was removed and the drug-loaded coated nanoparticles were redispersed in
a cell culture medium. During the incubation of the loaded nanoparticles with cells,
delivery of colchicine into the cell interior is expected upon internalization of the lipid-
coated nanoparticles or upon contact with the cell membrane. Even though the entry
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(a) (b)
Figure 9.4: Fluorescein delivery profile from lipid-coated CMS. (a) The uncoated
CMS () show a prompt release of fluorescein within 10 min, indicated by the steep
increase of released fluorescence. In contrast, no release is detected from the lipid
supported nanoparticles (N). Just after Triton addition (at 60 min), a fast release
of fluorescein is observed due to lysis of the lipid. (b) Scheme and photo of the
fluorescence cuvette used for the release experiments: the sample is confined in the
tube and closed by a cap with a dialysis membrane; the volume of the fluorescence
cuvette is filled with water.
mechanism of the coated nanoparticles is not yet clear, one can conclude from the in-
vitro experiments, that the colchicine release can take place only upon lysis of the lipid
bilayer on the CMS nanoparticle surface.
To see the impact of colchicine-loaded, lipid-coated nanoparticles on cells, high res-
olution spinning-disk confocal microscopy was performed using two separate detection
channels, with the green channel monitoring the GFP-labeled tubulin expressed by the
HuH7 cells and the red channel measuring the fluorescence of the Atto 647 labeled CMS
nanoparticles.
Fig. 9.5(a) shows untreated HuH7 cells with the GFP-labeled network of microtubules
with an insert of colchicine-loaded lipid-coated CMS nanoparticles. HuH7-cells after 25
minutes of incubation of the particles are shown in Fig. 9.5(b). The microtubule net-
work still apears to be intact after this time. In contrast, after 120 min of incubation
(Fig. 9.5(c)) the individual microtubule filaments can hardly be recognized. The diffuse
green fluorescence arises from the deploymerized microtubules. Fig. 9.5(c) shows the
cross section of the same HuH7 cell as displayed in Fig. 9.5(b), where some internalized
nanoparticles are visible in the green cell medium. Twentyfour minutes later (at a total
time of 144 minutes, Fig. 9.5(d)), the morphology of the same cell has changed consider-
ably: a shrunk and flat cell surface is observed, clearly indicating cell death. This can be
attributed to colchicine delivery and release from the lipid-coated nanoparticles, followed
by binding of colchicine to tubulin, microtubule depolymerization and cell death.
To prove that the microtubule depolymerization and cell death are caused by the
colchicine drug and not by the carrier itself, unloaded lipid-coated CMS nanoparticles
were incubated with HuH7 cells. Fig. 9.6(a) shows a living HuH7 cell with an intact
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Figure 9.5: Colchicine delivery from the lipid-coated CMS on HuH7 liver cancer
cells, stably expressing GFP-labeled tubulin. (a) Untreated HuH7 cells show a GFP-
labeled well-structured microtubule network (green). (b) CMS nanoparticles are la-
beled with Atto 647 (red). Colchicine is adsorbed into the mesopores and then capped
with a POPC lipid bilayer. The POPC-coated CMS nanoparticles with colchicine are
injected into the culture medium of the liver cancer cells. After 25 min, the nanopar-
ticles have not been internalized. (c) After 120 min the internalized nanoparticles
deliver colchicine into the cell. The microtubule network disappears and a diffuse
fluorescence due to microtubule depolymerization is observed. (d) Side view of the
HuH7 cell represented in Fig. c, where the internalized nanoparticles (in yellow, due
to the overlay of green and red colors) are visible. Several other nanoparticles (in
red) are on top of the cell. (e) After 144 min the cell morphology is disintegrated,
confirming cell death.
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Figure 9.6: Reference experiment - exposure of living HuH7 cells to unloaded CMS
and to dissolved colchicine. (a) HuH7 cells (green) after 2 hours of incubation with
POPC-coated CMS without colchicine stay alive. (b) Effect of dissolved colchicine
from POPC-coated CMS confined into the dialysis-capped tube on HuH7 cells. After
6 hours the microtubule network of the HuH7 cells ist still intact, thus the dissolved
colchicine in the cell culture medium does not induce the tubulin depolymerization
and cell death.
microtubule network after 2 hours incubation with the lipid-coated nanoparticles. In-
ternalization of the particles was confirmed by a z-stack through the cell volume and by
the observation of typical intracellular motion of nanoparticle-filled endosomes along the
microtubular network of the cells. Hence, cell death is not caused by the lipid-coated
carrier, but by the effect of the released colchicine molecules.
It is known that colchicine has a small but finite permeability across cell membranes
and thus may also be able to cross the lipid bilayer of the coated nanoparticles. To in-
vestigate the effect of free colchicine which potentially crossed the membrane coating of
the nanoparticles, the in-vitro dialysis set-up was applied to the live cell imaging experi-
ment. The cells were exposed to the same concentration of colchicine-loaded lipid-coated
nanoparticles as used in the in-vivo experiment described above. Even after 6 hours of
exposure to free colchicine diffusing out of the drug-loaded lipid-coated nanoparticles,
the microtubule network remained intact and no cell death was observed (Fig. 9.6(b)).
This finding clearly shows that the amount of colchicine leaking out of the lipid bilayer
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into the medium is too low to trigger cell death. Hence, the cell death observed in the
first in-vivo experiment is attributed to the nanoparticle-mediated colchicine delivery
into the cancer cells.
The in-vivo delivery experiments have shown, that the lipid coated nanoparticles
deliver drugs into cells with a strongly enhanced efficiency compared to the direct cellular
uptake of drugs, which are diluted in the medium surrounding the cell. This concentrated
delivery of drugs into cells mediated by the lipid coated nanoparticles could be important
to pharmaceutical treatment, particularly chemotherapy. Highly concentrated doses of
drugs could be efficiently transported into cells, whereas the overall dosis given to the
patient could be reduced.
9.6 Future investigations and further applications of the
lipid-coated nanoparticles
The fluorescence cross-correlation spectroscopy experiments confirmed that the lipids
assemble to a bilayer around the nanoparticles thereby forming a monodisperse, stable
colloidal suspension in aqueous solution. Hence, they show, that solvent exchange pro-
vides an efficient and reproducible method to encapsulate individual CMS nanoparticles
of 50 nm diameter by an intact lipid bilayer. The in-vitro release experiments showed,
that they form a defect-free lipid bilayer which acts as a cap-system, preventing the dif-
fusion of guest molecules out of the mesoporous structure of CMS nanoparticles. Thus,
the lipid coated nanoparticles build a tunable release-on-demand system. Their abil-
ity to efficiently deliver and release drugs into cells was shown by in-vivo experiments.
The release mechanism is not yet understood. To elucidate the release mechanism into
more detail, super-resolution microscopy or single particle tracking studies could provide
valuable insight. Better knowledge of the release mechanism would in its turn allow for
improvement of drug design.
The lipid bilayer facilitates polymer-coating, for instance PEGylation is easily done by
addition of DSPE-PEG to the lipid solution. As shown in chapter 8, this could prolong
the circulation time of the nanoparticle drug delivery system and hence, drastically
enhance its efficiency.
Integration of receptor proteins into the lipid bilayer could target cells specifically and
improve the uptake mechanism as well as enhance the efficiency of the nanoparticle drug
delivery system. This could, for instance, be done by attaching EGF, GE11 or other
receptor proteins via PEG-bridges to the lipids. The PEG molecules would prevent the
proteins from inserting deeply into the bilayer where they might not be detected by the
cell. EGF and GE11 are known to stimulate vesicle fusion as uptake mechanism, which
is much more efficient than endocytosis. Consequently, drug delivery could be improved
by attaching these molecules to the lipid bilayer.
Moreover, the efficient delivery of the lipid-coated nanoparticles could also be used
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Figure 9.7: Nanobodies delivered into a HeLa (GFP-PCNA) cell via POPC-coated
CMS nanoparticles. The small, green particles are the Atto 488-labeled nanobodies
diffusing in the cell. Large aggregates of the nanoparticles (yellow) are not taken up
by the cells.
to transport molecules and nanometer-sized particles, other than drugs, into cells. One
example would be a living cell staining method. So far, there is no method to stain cells
while they are alive, unless they express fluorescently labeled proteins. Fluorescently
labeled nanobodies ( [95]) made from alpaca antibodies, provide an option for live cell
staining. However, they are taken up by cells in a very inefficient way, which does
not allow for accumulation of a sufficient amount of nanobodies needed in the cells for
fluorescence microscopy. The nanobodies are small enough (about 2 nm) to fit into the
pores of the CMS nanoparticles. Hence, the lipid-coated nanoparticles could serve as an
efficient carrier system for staining of living cells by nanobodies. A proof of principle
is given by first fluorescence microscopy experiments showing a big amount of green,
GFP-labeled nanobodies internalized into living cells (Fig. 9.7).
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10 Probing the viscosity in
Dictyostelium discoideum cells
Chapter 6 provided the basic concepts and understanding to perform FCS experiments in
living cells. The findings showed, that changes of the viscosity due to crowding strongly
influence the results of FCS measurements. Hence, FCS can be used to probe the vis-
cosity in living cells. Here, FCS is employed to study the viscosity in dictyostelium
discoideum cells. With different mutants the local effective viscosity is probed in the
cytoplasm as well as in the actin cortex. The effect of drug treatment on the polymeriza-
tion of the cell is studied using latrunculin and jasplakinolide. Since FCS measures vis-
cosity at very small volumes and short timescales compared to fluorescence microscopy,
the experiments allowed for the detection of actin waves and for investigation of their
viscosity.
10.1 Probing the viscosity in living cells with
Fluorescence Correlation Spectroscopy
Viscosity in cells varies a lot depending on the outer conditions, the cell type and the
region of the cell. Both, polymerization of the actin network and crowding by a vari-
ety of heterogeneous, polydisperse macromolecules, have a strong influence on the cell’s
viscosity [43]. Since diffusion depends on viscosity, this has immediate consequences on
the mobility and thus on reaction rates and transport properties within the cell. To gain
a better understanding of cellular processes, many theoretical as well as experimental
studies are performed on diffusion in confined, crowded systems and the impact on reac-
tions within these systems [96–100]. All theoretical models and computer simulations,
which adress this topic, need to rely on experimentally determined viscosities to describe
the diffusion characteristics of a cell in a most realistic way [101]. Hence, it is desirable
to measure viscosity in cells as accurate as possible.
Many experiments have been performed to measure effective viscosities in cells using
micrometer-beads [98,99]. Values resulting from these experiments are valid for objects
of micrometer size only, since diffusion in crowded systems depends on the tracer size.
Another method to probe effective viscosities in vivo is fluorescence microscopy [102].
This technique explores diffusion on rather long time scales and in quite large volumes.
The confocal setup allows FCS to probe the local viscosity in a very small, well-defined
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volume. Furthermore, FCS uses small fluorescently labeled tracer proteins such as GFP
and measures diffusion on much shorter time scales compared to conventional fluores-
cence microscopy. Viscosity enhancement due to binding to the tracer molecule can be
discriminated from an increase caused by changes of the local environment by comparing
the diffusion characteristics in the cell with the results obtained from cell lysate. With
these properties, FCS complements conventional techniques perfectly.
Challenges for viscosity measurements are time dependent viscosity changes and strong
local variations, where regions of equal viscosity are confined to very small volumes, such
as the actin cortex which is only a few nm thick. Both challenges can be adressed fairly
well with FCS. The comparatively small confocal volume can be even further reduced
by a confinement of the probe volume. In the case of cell experiments, different mutants
with fluorescently labeled proteins, which appear only in the region of interest, can be
used to reduce the probe volume. To probe, for instance, the actin cortex, a mutant with
GFP labeled proteins, which exist only in the cortex, is used. Time-dependent viscosity
changes can be measured with FCS as long as they vary on time scales longer than the
measurement time (i.e. 10-20 s). One such time dependent phenomenon of very strong
current research interest are actin waves. They occur e.g. in dictyostelium cells, when
they sense a barrier or food [103]. They consist of polymerization fronts which move
within the cell and hence change the local viscosity with time. Since they appear on a
time scale equal to a typical FCS measurement time, they can be detected.
Laser Scanning Microscopy was used to image the cells and to position the focus
at regions of interest (Fig. 10.1). Autocorrelation curves obtained from in-vivo or
lysate FCS experiments were fitted with the modified autocorrelation function for three-
dimensional Brownian diffusion, which takes the influence of the polymer network into
account [104]:
G(τ) = 1 +
1
N
· 1
1 + ( t
τD
)β
1√
1 + S−2( t
τD
)β
(10.1)
The fitting parameters yield the number of particles in the focal volume, N , and the dif-
fusion time, τD. The additional parameter β reveals the influence of the polymer network
and represents the scaling exponent indicating the deviation from normal diffusion:
〈r2〉 = Dtβ (10.2)
The diffusion coefficient D was determined with equation 4.5 and equation 4.7 was used
to deduce the viscosity η relative to the viscosity in aqueous solution η0:
η
η0
=
D0
D
(10.3)
where D0 denotes the diffusion coefficient in aqueous solution.
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(a) (b)
Figure 10.1: Laser Scanning Microscopy images the cells on the cover slide (a) and
allows one to position the focus at regions of interest (b).
(a) (b) (c)
Figure 10.2: (a) Intensity trace exhibiting strong irregular fluctuations on large
time scales. (b) Intensity trace with uniform fluctuations. (c) Autocorrelation curve
obtained from an experiment in the mutant expressing free GFP.
10.2 Viscosity in the cytoplasm of dictyostelium cells
In order to determine the effective local viscosity in dictyostelium cells, FCS measure-
ments were performed on different mutants. For all mutants, the intensity time traces
obtained from these experiments could be distinguished into two groups: some showed
strong, irregular fluctuations on large time scales (in the range of seconds), whereas
others showed only small uniform fluctuations on a µs time scale. Examples of inten-
sity traces of both groups are given in Fig. 10.2. Intensity traces which exhibit strong,
irregular fluctuations were already observed by Ruchira and coworkers [105] and can
be attributed to movements in the cytoplasm, e.g. by the nucleus or diffusing vesicles
passing the confocal volume. For further evaluation only intensity traces with uniform
fluctuations were chosen. They were analysed as described above and yielded autocor-
relation curves similar to the one depicted in Fig. 10.2(c).
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Evaluation of experiments on a mutant with free GFP diffusing within the cytoplasm
showed a mean scaling exponent β of 0.84 indicating slightly subdiffusive motion. The
mean diffusion time was determined to be 168 µs yielding a diffusion coefficient of
59 µm2s−1. This is 2.5 times slower than the values obtained from lysed cells, which
showed a diffusion coefficient of 148 µm2s−1 and normal diffusion (β = 0.97). Control
measurements on purified eGFP (diffusion coefficient: 157 µm2s−1, β = 1.01) compare
fairly well with the values from the lysed cells. Hence, additional slowdown of the GFP
diffusion due to binding of cellular components can be excluded and the slowdown of
the diffusion coefficient can be fully attributed to an enhanced viscosity of 2.47 mPas in
the cell.
This increase of the viscosity is slightly less than reported for other eucaryotic cells [40].
Potma et al. [106] measured for dictyostelium cells under various conditions an increase
of the viscosity by a factor of 2-4. Compared to these data, the increase of the viscosity of
2.5, that was determined here for the cytoplasm is at the lower end, indicating a low level
of polymerization. This might be due to the immobilization of the cells with aminosi-
lanized surfaces. Indeed, Ruchira et al. [105] found a reduced viscosity in immobilized
cells. However, the enhancement is still larger as to be explained by macromolecular
crowding of monodisperse solutions. Experiments on model systems of monodisperse
vesicle solutions yield a factor of 2 for the viscosity increase and do not show any signs
of subdiffusion [38]. The enhancement of the viscosity beyond macromolecular crowding
effects and the subdiffusivity of the motion indicated by the scaling exponent of 0.84
might be explained by effects due to polymerization of the actin network. Dauty et
al. [61] report a drastically increased reduction of DNA diffusion in polymerized in-vitro
actin networks compared to solutions crowded by spheres. To see whether this is the
the reason of the measured viscosity enhancement, experiments were performed on a
mutant expressing GFP-labeled actin. As the mutant with free GFP, this one shows
the same slowdown of diffusion by a factor of 2.5 compared to the lysate. The diffusion
coefficient of the actin in the cell was determined to be 41 µm2s−1 and in the lysate
it was 105 µm2s−1. Also the scaling exponents were very similar compared to the free
GFP mutant: 0.82 for the actin in the cell and 0.97 for the lysate. After this verification
that the same effect is measured with both mutants, the hydrodynamic radius of actin is
calculated to find out about its polymerization. Using equation 4.7, the hydrodynamic
radius of actin was calculated to be 2 nm, compared to a radius of 1.5 nm for GFP.
The value for actin is consistent with its size reported in literature [107]. From that one
can conclude, that under the experimental conditions actin is present as a monomer and
not polymerized in the cytoplasm of the cells. Hence, the changes in diffusion (i.e. the
strong enhancement of the viscosity and the subdiffusive motion) cannot be explained
by effects due to the polymerized network. An explanation might be that the polydis-
persity of macromolecules in the cells (cf. Fig. 10.4) leads to anomalous diffusion and a
stronger increase of the effective viscosity compared to monodisperse model solutions.
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10.3 Viscosity in the actin cortex of dictyostelium cells
Compared to the thickness of the actin cortex of a few nm, the focus size of 0.5 µm is
too large to probe the actin cortex only. A viscosity measurement of the actin cortex
would therefore always be determined by the surrounding regions, in this case by the
viscosity of the cytoplasm. This restriction can be circumvented with the help of a
mutant expressing GFP-labeled LIM protein, which is present only in the actin cortex
under normal conditions. This allows one to measure the viscosity in the actin cortex.
Experiments with this mutant yield a diffusion coefficient of 38 µm2s−1 in the cells and
150 µm2s−1 for the lysed cells. The hydrodynamic radius of LIM proteins calculated
from the diffusion coefficient in lysed cells is 1.5 nm. Since this is a size typically found
for unbound, freely diffusing proteins, again, an additional slowdown due to binding of
other proteins to the tracer molecule can be excluded.
Comparison of the diffusion constant in the cell and in the lysate shows an increase of
the effective viscosity in the actin cortex by a factor of 3.9 compared to aqueous solution
and by a factor of 1.55 compared to the non-polymerized cytoplasm. Since the actin
cortex is known to consist of a highly polymerized actin network and the LIM protein
is expressed only during polymerization of actin, this additional increase of the effective
viscosity can be explained by the influence of the actin network. In vitro experiments
on actin diffusion confirmed a scaling law, which was predicted by the reptation model
for flexible chains and relates the diffusion coefficient D with the actin concentration ca
and the mesh size ξ of the actin network [108]:
D ∝ c−1a ∝ ξ2 (10.4)
This scaling law yields an increase of the actin concentration in the actin cortex by a
factor of 1.55 compared to the cytoplasm and a corresponding decrease in the mesh size
of the actin network by a factor of 0.4.
The scaling exponent reveals the polymerization of the actin cortex, as well. In the
LIM mutant it could be determined to be 0.79 in the cells and 0.99 for the lysed cells,
indicating normal diffusion for the lysate and subdiffusive motion in the cortex. The
value in the cells agrees very well with the value of 0.75 reported for example for the
actin cortex of amoebae [109] and for in-vitro actin networks [104]. Furthermore, it
is consistent with the value of 0.75 predicted for actin filament chains by theoretical
calculations.
10.4 Influence of jasplakinolide
Cells of the actin mutant were treated with 5 µM jasplakinolide, which leads to poly-
merization of the actin in the cytoplasm. As expected, the results in this case are very
similar to those in the actin cortex: β = 0.74 and the diffusion coefficient 29 µm2s−1,
yielding a viscosity, which is enhanced by a factor of 3.7 compared to aqueous solutions.
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Figure 10.3: Histograms of the scaling exponents in the actin mutant without drugs
(a) and upon jasplakinolide (b) and latrunculin (c) treatment and histograms of the
diffusion times measured in the actin mutant without drugs (d), and upon jasplaki-
nolide (e) and latrunculin (f) treatment. While the distributions of the parameters
of untreated and jasplakinolide treated cells are fairly narrow, the parameters of cells
treated with latrunculin exhibit a broad distribution.
Hence, jasplakinolide at the concentration used polymerizes the cells up to an extent as
in the actin cortex, leading to the same diffusion conditions. Based on these findings,
cells treated with jasplakinolide can serve as an easy to access model system to probe
viscosity and diffusion characteristics of the actin cortex. Furhtermore, variation of the
concentration of jasplakinolide will allow for regulation of the degree of polymerization
and thus for experiments on the influence of polymerization on the effective viscosity.
10.5 Latrunculin induced actin waves
Latrunculin A was added to the actin mutant at a concentration of 5 µM . The results of
the experiments are shown in Fig. 10.3. While the scaling exponents and diffusion coef-
ficients of untreated cells and cells treated with jasplakinolide are well centered around
a mean value, both scatter a lot in cells treated with latrunculin. Scaling exponents
range from 0.5 to 0.9 and diffusion coefficients from about 10-70 µm2s−1. Thus, some
experiments show diffusion as in unpolymerized, untreated cells, some reveal diffusion
characteristics as under conditions of complete polymerization like in the actin cortex or
after jasplakinolide treatment and some are located somewhere in between the two cases.
Since all other experiments without latrunculin show much more homogeneous results,
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Figure 10.4: (a) Laser Scanning Microscopy image of dictyostelium cells expressing
GFP labeled actin after treatment with latrunculin A. (b) Schematic drawing of a cell
surrounded by the actin cortex (green) and with the cytoplasm crowded by polydisperse
macromolecules. (c) Schematic drawing of a cell with a polymerization front of an
actin wave (red line) moving with velocity v.
the strong scattering of the results can be attributed to the influence of latrunculin and
is not caused by data uncertainties due to instrumentation and analysis.
Latrunculin A at a concentration of 5 µM is reported to induce actin waves in
dictyostelium cells [110]. These waves move with a velocity of a few µm/min [110,111]
and sometimes they stop and change direction. Since the actin front of the waves is of
a size of roughly 2 µm, the confocal volume is filled by an actin front for about 10-15
s (cf. Fig. 10.4). Thus, an actin front entering the confocal volume just before the
measurement starts fills the confocal volume for the whole time of a 15 s measurement,
especially, when it stops there and changes direction. Hence, the low scaling exponents
and the high viscosities indicating a highly polymerized actin network as measured in
some of the experiments on latrunculin treated cells can be attributed to such polymer-
ization fronts of actin waves and reveal their local effective viscosity. Scaling exponents
and viscosities similar to those of untreated cells result from regions in the cytoplasm,
which are not influenced by actin waves. Experiments showing values of scaling expo-
nents and viscosities in between unpolymerized and completely polymerized conditions
could result from regions of actin waves that are less polymerized or from actin waves
that passed the focal volume during the experiment which then lead to a measurement
of the time averaged effective viscosity. Finally, the heterogeneity of the data can be well
explained by the actin waves. Since only the polymerization moves with the wave, but
no molecules at all (all molecules involved are constantly destroyed and renewed), actin
waves cannot be detected by direct observation of molecular movements. So far, the only
method was to use mutants expressing GFP labeled proteins that are present in such
waves only. Here it was shown, that FCS viscosity measurements allow for the detection
of actin waves independent of these proteins and at the same time, they reveal for the
first time the viscosity in actin waves. This determination of the effective viscosity in
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actin waves could be of great interest for computer simulations of these waves.
In general, the experiments of this chapter have shown that FCS is a powerful tool to
determine effective viscosities in cells. Particularly, it allows for very accurate determi-
nation of changes of the local effective viscosity by comparing viscosities in cells relative
to the value in lysate.
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Correlation Spectroscopy
Chapter 6 provided evidence, that it would be desirable for measurements in complex
media to use a technique with reduced scattering, such as two-photon fluorescence cor-
relation spectroscopy. In-vivo experiments in cells, as shown in the previous chapter
would also profit from two-photon excitation. To this end, a home-built two-photon
microscope which can be used for laser scanning microscopy as well as for fluorescence
correlation spectroscopy was set up. This chapter first compares one- and two-photon
microscopy, then the set-up is described and first results of auto- and cross-correlation
measurements are shown.
11.1 Comparison of conventional one-photon- and
two-photon microscopy
Two-photon excitation is performed at wavelengths of about double the size compared
to one-photon excitation. Hence, for most dyes, wavelengths in the infrared are used for
two-photon excitation. Since scattering increases with the frequency ω4, it is drastically
reduced in the infrared compared to the visible regime, which is usually used for one-
photon excitation. This very much improves the performance of experiments in living
cells which exhibit a strong background signal due to scattering in the case of one-photon
excitation [112]. Furthermore, this decrease in scattering enhances the signal to noise
ratio in stronlgy scattering media, such as plasma or tissue and reduces artifacts due
to focus distortion in FCS experiments, which are performed in complex soft matter
systems, as shown in chapter 6.
Another favourable characteristics of two-photon microscopy is its inherently confined
excitation volume [17, 112]. Absorption of light is limited to the focus where photon
densities are high enough to allow for two-photon processes. This has great potential for
medical applications, such as photodynamic therapy, which can exploit this confinement
to precisely address treatment without affecting healthy tissue [112]. In research, this
restriction of the excitation volume was used for instance, for activation of photoactivable
proteins at well-defined positions. Since cells are damaged by intense light, in two
photon microscopy, damage is reduced to a very small volume, thus making two-photon
microscopy a powerful tool for cellular applications [9, 113, 114]. However, for such
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applications, the high photon densities in the focus, which exceed those used for one-
photon excitation by far, have to be considered, particularly their effect on the cell at
the focal volume [60,115].
Due to the sharply defined and very small focal volume, two-photon excitation is
very well suited for fluorescence correlation spectroscopy. Here, the intrinsically con-
fined focus allows for a very simple optical setup, without the need for confocal optics
which employs two pinholes to confine the focal volume of a one-photon setup. An-
other advantage of two-photon excitation for fluorescence correlation spectroscopy is the
broadening of excitation spectra of commonly used dyes due to the modified selection
rules of a two-photon process as compared to one-photon excitation [116, 117]. Con-
sequently, many dyes with well separable emission spectra can be excited at the same
wavelength. This allows for dual-colour cross-correlation experiments with only one ex-
citation wavelength, thus the challenge to match the foci of the two excitation colours
as in one-photon cross-correlation experiments is inherently solved.
11.2 Setup of the two-photon microscope
In order to benefit from the advantages of two-photon excitation concerning experiments
in complex, scattering media and particularly in cells [113], a two-photon microscope was
built. One future application should be to measure GFP-expression in bacteria, since
bacteria scatter a lot and are not accessible for FCS experiments with our commercial
one-photon microscope. E. coli bacteria have a typical size of 1µm×1µm×3µm, there-
fore the setup had to be very stable and the piezo-scanners very precise. The components
of the microscope should be easily accessible to allow for realignment and customized
extensions, thus the whole setup was home-built. Fig. 11.1 schematically shows the
setup including the beam path and all optical components. The excitation source is a
femtosecond-pulsed tunable IR-laser (Chameleon, Coherent). The beam passes several
OD-filters, which allow for regulation of the excitation intensity, and is directed by two
mirrors into the objective, which focusses the beam into the sample. The fluorescent
light of the sample is collected by the objective and directed into the detection path via
a dichroic mirror, which separates the fluorescence from the excitation light. The detec-
tion path consists of several high quality bandpass filters, which further discriminate the
fluorescence from excitation- and scattered light and allow for separation of two different
fluorescence colours for cross-correlation experiments. An optional beamsplitter divides
the beam into two, which each hit an avalanche photodiode (EG&G) for detection. The
detected signals are correlated by a hardware correlator (ALV, Langen) and displayed
on the computer. The sample chamber is fixed on two piezo-stages (Physik Instrumente)
which allow for precise scanning.
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Figure 11.1: Schematic drawing of the two-photon setup. The beam is emitted from
the IR-laser and via several mirrors it is directed into the objective, which focusses the
light into the sample. The fluorescence light collected from the objective is separated
from the emission light by a dichroic mirror and several bandpass filters. Finally, it
is directed into the APDs, which detect the emitted photons.
11.3 First results of auto- and cross-correlation
experiments
Fluroescently labeled vesicles were chosen as sample for the very first test measurements.
One vesicle carries several dye-molecules and hence exhibits a bright fluorescence signal
which should be easily detectable. Fig. 11.2(a) shows an autocorrelation curve from
Bodipy labeled vesicles of 100 nm diameter. This diameter can be used to calculate the
diffusion coefficient of the vesicles with equation 4.7 and hence the focal volume can be
determined with equation 4.5 and the fit parameters yielding a focal volume of 14 fl for
this setup. This value is fairly large compared to the value obtained from theoretical
calculations for two-photon excitation, according to [112]:
ωx = 0.61
λ
NA
ωz =
piλ
NA2
(11.1)
which lead to a value of 0.8 fl for the focal volume with the optical settings used here
(i.e. a numerical aperture NA = 1.2 and an excitation wavelength of 900 nm). The
discrepancy of the values obtained for the focal volume might be due to distortion of the
focus in the experiment and could be improved by further optimization of the alignment
and the excitation intensity.
As a second test sample quantum dots were used, which lead to a strong fluorescence
signal as well. Fig. 11.2(b) shows the distinct autocorrelation curve obtained from the
quantum dots. As a next step, dye solutions such as Alexa 488 should be tested. So
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(a) (b)
Figure 11.2: Autocorrelation functions of fluorescently labeled vesicles (a) and quan-
tum dots (b) obtained from the two-photon setup.
far, a clear intensity signal was obtained from dye solutions; successful measurements of
autocorrelation curves, however, are still a challenge. To this end, the signal-noise ratio
has to be improved by optimization of the alignment of the detection path and maybe
addition of further high-quality bandpass filters. Furthermore, the excitation intensity
and pulse width has to be optimized, since there is only a small regime of intensities
which lead to efficient two-photon excitation of the sample.
Two-photon FCS bears great potential for cross-correlation applications due to the fact
that two dyes with spectrally separable emission spectra can be excited simultaneously
with the same wavelength. Therefore, detection filters were chosen to have the option
of performing cross-correlation spectroscopy. As a proof of principle, cross-correlation
experiments on vesicles labeled with both, Texas Red and Bodipy, were performed. Fig.
11.3(a) shows the obtained curves of the autocorrelation of each single channel and their
cross-correlation. The effect of addition of vesicles labeled only with Texas Red on the
cross-correlation curve is shown in Fig. 11.3(b). The amplitude of the cross-correlation
function decreases, since the relative amount of vesicles carrying both dyes and thus
leading to the cross-correlation signal decreases with increasing amount of single colour
labeled vesicles. Hence, the experiments give evidence of successful cross-correlation
performance of the home-built two-photon setup and promise future applications for
instance for binding experiments.
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(a) (b)
Figure 11.3: Two-photon cross-correlation of vesicles labeled with Bodipy and Texas
Red. (a) Autocorrelation of the Bodipy-signal (green line) and the Texas Red-signal
(red line). The black line represents the cross-correlation of Bodipy and Texas Red
signal. (b) Cross-correlation of vesicles labeled with both, Bodipy and Texas Red (◦).
Upon addition of vesicles labeled with Texas Red only, the amplitude of the cross-
correlation decreases (O).
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12 Electrostatically coupled diffusion
of short ds-oligonucleotides on
cationic lipid membranes
Chapter 7 described experiments on diffusion of proteins, namely FVIIIa and annexin,
on a supported lipid membrane, which were performed to test whether they move in-
dependently or in a correlated manner. In future research similar measurements on
supported lipid bilayers could help unravel complex protein-membrane interactions in-
volving mechanisms as explained in chapter 5.3, since they allow for the investigation
of influences of the membrane composition or lipid rearrangements and of correlations
of proteins and lipids. To this end, DNA diffusing on a supported membrane serves
as excellent model system, which is sufficiently well understood. As a proof of princi-
ple for such FCS experiments on supported lipid bilayers, measurements on diffusion of
short ds-oligonucleotides on supported cationic lipid membranes were performed. This
chapter describes these test experiments, including autocorrelation measurements on
fluorescently labeled lipids and on DNA diffusing on the membrane under various condi-
tions (i.e. different salt concentrations of the buffer, different DNA lengths, an applied
electric field) and discusses cross-correlation studies on the diffusion of DNA and lipids.
12.1 Fluorescence Correlation Spectroscopy in two
dimensions
Proteins as well as DNA bound to a supported lipid membrane experimentally realizes
a 2D-confinement of polymers (Fig. 12.1). Several groups have reported on FCS ex-
periments on two dimensional samples [118,119]. They all studied lipid diffusion within
membranes. These measurements face one major challenge: membranes are only a few
nm thin and therefore, the setup has to be very stable to guarantee for the focus to
stay within the membrane and illuminate it at a constant spot size. Once, a very stable
focus position is achieved, the experiments can be carried out as in three dimensional
samples. Fig. 12.2(a) shows a typical intensity time trace obtained from lipids diffusing
within a membrane and Fig. 12.2(b) displays the corresponding autocorrelation curve.
Such autocorrelation curves can be described with equation 4.4 modified for the case of
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Figure 12.1: DNA diffusing on a supported lipid bilayer, representing a confinement
of polymers into two-dimensions. For FCS experiments on membranes the focus po-
sition needs to be very stable since small variations in the height lead to an immediate
change of the size of the illumination spot and hence strongly influence the measure-
ment.
two dimensions [118]:
G(τ) =
1
N
· 1
1 + τ
τD
(12.1)
The red line in Fig. 12.2(b) represents a fit according to this equation. Since the
membrane is thinner than the focal height and due to the Gaussian shape of the focus,
the size of the focal spot on the membrane varies with its position in the focus (Fig. 12.1).
Thereby, the position of maxiumum intensity, does not necessarily coincide with the
centre position of the focus. Hence, the focal width can not be taken from a calibration
measurement in solution, it rather has to be determined by a z-stack of measurements.
Both, the particle number and the diffusion time resulting from these measurements
exhibit a parabolic dependence on the z-position of the focus. Fitting these parabolae
according to [118]:
N = N0(1 +
λ20∆z
2
pi2n2ω40
) (12.2)
and
τD =
ω20
4D
(1 +
λ20∆z
2
pi2n2ω40
) (12.3)
yields the particle density, their diffusion coefficient, D, and the focal width, ω0.
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(a) (b)
Figure 12.2: (a) Typical intensity trace and (b) autocorrelation curve of DNA diffus-
ing on a supported lipid membrane. The red line represents a fit according to equation
12.1.
If the illumination and fluorescence distributions are Gaussian, the autocorrelation
function can be written in terms of the mean square displacement 〈r2〉:
G(τ) =
1
N
· 1
1 + 〈r
2〉
ω2
(12.4)
where ω is the beam waist. The mean square displacement of typical lipid diffusion
within the supported membrane is shown in Fig. 12.3(a) in a logarithmic plot. It
coincides very well with a line of slope 1, which indicates normal diffusion behaviour.
The diffusion coefficient obtained from these measurements is 5 µm2s−1. These findings
are in exact agreement with data from literature, which report the same value for the
diffusion coefficient and normal diffusion for lipids in membranes [118]. Hence, they
serve as a very good proof of principle for the performance of FCS measurements on
two-dimensional systems.
12.2 DNA diffusion on supported lipid bilayers
In this thesis, for the first time FCS measurements were performed on molecules which
diffuse on a supported lipid membrane and thus are confined to two-dimensional diffu-
sion. The rectangular data points in Fig. 12.3(b) represent the mean square displacement
obtained from an FCS experiment on 20 basepair oligonucleotides diffusing on a DOPC-
membrane containing 20% positively charged DOTAP lipids. For comparison, the mean
square displacement of lipids is shown in the same graph (triangles). The data sets can
be described by parallel lines with slope 1, indicating normal diffusion. Compared to
the mean square displacement of the lipids, that of the DNA is shifted towards slower
diffusion. Quantitative evaluation yielded a diffusion coefficient of 2 µm2s−1. The lipid
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(a) (b)
Figure 12.3: (a) Mean square displacement of lipid diffusion within a supported lipid
bilayer. (b) Mean square displacement of 20 bp DNA diffusing on a supported lipid
membrane (). For comparison the mean square displacement of lipid diffusion (4)
is shown as well. The red lines represent linear fits according to normal diffusion.
diffusion within the membrane does not change upon binding of the DNA and revealed
again a diffusion coefficient of 5 µm2s−1.
To study the influence of the membrane composition on the diffusion of the DNA, the
concentration of charged lipids was varied. Fig. 12.4(a) shows first results on the depen-
dence of the diffusion coefficient of 20 basepair oligonucleotides on the concentration of
positively charged DOTAP lipids. Except for the value at 30% charged lipid, the diffu-
sion coefficients decrease with increasing charge concentration, indicating a slow down of
the movement. However, the data need to be confirmed before the exhibited behaviour
can be discussed and explained, since data of two-dimensional FCS experiments scatter
a lot and a good statistics is necessary for reliable data.
Schlagberger et al. [120] found an interesting dependence of the DNA diffusion in
solution on the salt concentration, consisting in a shallow minimum of the diffusion
coefficient at a screening length comparable to the polymer length. In order to investi-
gate the salt-dependence of DNA diffusion on membranes, the diffusion of 40 basepair
oligonucleotides on a membrane with 20% charged lipid was measured as a function of
the NaCl concentration of the buffer. First results are shown in Fig. 12.4(b). Also in
this case, statistics needs to be improved to allow for interpretation of the data. Despite
the low statistics, all experiments on DNA diffusing on lipid membranes show the ability
of FCS to measure diffusion confined to two dimensions and promise a great potential
to gain further insight into molecules interacting with and diffusing on surfaces such as
lipid membranes.
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(a) (b)
Figure 12.4: Dependence of the diffusion coefficient of DNA diffusing on supported
lipid bilayers (a) on the charge content (i.e. DOTAP concentration) of the membrane
and (b) on the salt concentration of the buffer solution.
12.3 Cross-correlation-experiments on DNA diffusion on
supported lipid membranes
Kahl et al. [121] proposed a biased reptation model for the interaction of DNA with
cationic lipid membranes in which the cationic lipids of the membrane assemble under-
neath the anionic DNA strands. Hence, the diffusive motion of the cationic lipids should
be correlated to the DNA movement. Cross-correlation experiments on DNA diffusing
on supported lipid membranes, which contain fluorescently labeled cationic lipids could
give evidence of such a correlated movement. While cross-correlation of DNA with the
uncharged lipids of the membrane should constantly equal 1, indicating the absence of
correlated movement, the cross-correlation of DNA with the cationic lipids should reveal
a distinct curve.
Cross-correlation experiments were performed with Cy5-labeled DNA and Bodipy-
labeled uncharged lipids. Fig. 12.5(a) shows the distinct autocorrelation curves of DNA
and uncharged lipids (red and green curves, respectively). No cross-correlation could
be detected (black line in Fig. 12.5(a)), indicating the independent movement of DNA
and uncharged lipids, as expected. The results of cross-correlation measurements on
Cy5-labeled DNA and NBD-labeled cationic lipids (DOTAP) are shown in Fig. 12.5(b).
The autocorrelation curves are similar to those obtained from the measurement with
uncharged lipids. The cross-correlation curve exhibits a distinct curve, which might
indicate correlation of the movement of DNA and charged lipids and hence might confirm
the model of Kahl et al. [121]. However, further evaluation showed, that this cross-
correlation is mainly caused by crosstalk of NBD into the red channel and the large
contribution of crosstalk does not allow for a discrimination of cross-correlation due to
correlated movement of DNA and lipids. To obtain reliable results from cross-correlation
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(a) (b)
Figure 12.5: Cross-correlation experiments of DNA and lipids. (a) Cross-correlation
of DNA and uncharged DOPC lipids. Whereas the autocorrelation of DNA and lipids
reveal distinct curves, the cross-correlation of DNA and uncharged lipids is constant.
(b) Cross-correlation of DNA and cationic DOTAP lipids. The autocorrelation as
well as the cross-correlation exhibit distinct curves.
experiments, charged lipids labeled with a better dye than NBD, showing less crosstalk,
such as Alexa 488 are necessary. Then, cross-correlation can contribute to gain an
insight into DNA interaction with cationic lipid membranes. Once this is achieved, cross-
correlation experiments on supported lipid bilayers could allow for the investigation of
protein-membrane interactions and correlations between bound proteins and lipids and
thereby contribute to the explanation of complex binding mechanisms.
12.4 Electrophoresis
Gel-free electrophoresis for separation of macromolecules in microfluidic devices, capil-
laries or at surfaces is very desirable, since gel-electrophoresis is a very long procedure.
Many solutions have been proposed to that issue [122, 123]. Applying an electric field
to DNA bound to lipid membranes is one possible realization of gel-free electrophore-
sis [121]. In this section, FCS was employed to investigate the change of movement of
DNA diffusing on a membrane upon application of an electric field.
Fig. 12.6(a) shows the autocorrelation curve of the DNA diffusing on the lipid mem-
brane before the electric field was applied. It shows normal diffusion with a diffusion time
of 3.8 ms. After this measurement an ac-electrical field of 0.1 Hz, which is slow enough
to avoid demixing of the membrane, was applied. The resulting autocorrelation curve
(Fig. 12.6(b)) is shifted towards shorter times and hence reveals a faster movement.
Analysis with equation 12.1 for normal two-dimensional diffusion reveals a fitting curve
(red curve), which does not fully describe the measured data (see also the residuals).
Introduction of anomalous diffusion via the parameter β as done for three-dimensional
88
12.4 Electrophoresis
(a) (b)
Figure 12.6: Electrophoresis of DNA on lipid membranes. (a) Autocorrelation of
DNA diffusing on a lipid membrane without electric field. The red line represents
a fit according to normal two-dimensional diffusion with the residuals shown below,
indicating a very good fit quality. (b) Autocorrelation of DNA diffusing on a lipid
membrane with an applied electric field. The shorter decay time reveals the acceler-
ation of the DNA by the electric field. The red line representing a fit according to
normal two-dimensional diffusion does not fully describe the data, as seen also by
the strong deviations of the red residuals. Introduction of a scaling exponent which
accounts for directed movement allows for a better fit (blue line and blue residuals).
diffusion in chapter 10, allows for a full description of the autocorrelation curve (blue
line), yielding a diffusion time of 1.7 ms, which is approximately twice as fast as the
diffusion without electric field. The exponent β obtained from the fit is 1.4, indicat-
ing a directed movement, whereas a fit to the measurement without electric field yields
normal diffusion with an exponent β of 1. Thus, the FCS experiments show a faster,
directed movement of the DNA on lipid membranes upon application of an electric field,
as one would expect in this case. Further experiments have to confirm these findings.
A combination with cross-correlation analysis could provide information on the lipid
diffusion and its interaction with the DNA movement and hence contribute to a better
understanding of two-dimensional electrophoresis on membranes, which then could help
to design and improve applications.
In general, the results of this chapter prove that FCS can be performed to measure
two-dimensional diffusion on surfaces such as membranes. In particular, cross-correlation
experiments on particles diffusing on membranes show great potential for analysis of
correlations in the movement of particles and the membrane or of dependencies and in-
dependencies of the diffusion of two different species of particles bound to a membrane,
as was done in the case of activated FVIII and annexin. In future research such experi-
ments could contribute substantially to the understanding of complex protein-membrane
interaction mechanisms.
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The results of this work have demonstrated that binding of FVIII to membranes within
coagulation is a highly regulated and complex process. The experiments on its regulation
by annexin in plasma have shown that it is subject to even more regulatory interactions,
which are not yet understood. Investigations on the interaction of FVIII with further
coagulation proteins such as FIX and FX and their influence on FVIII binding to mem-
branes could contribute to a better understanding of this part of the coagulation cascade.
This extended knowledge of the underlying biochemical and biophysical processes could
provide a basis for systems biology to model and simulate the coagulation cascade, since
simple rate equations with constant rates, which are used so far, are not sufficient for
a reliable description. This becomes evident for instance by the strong dependence of
FVIIIa binding to membranes on their PS-content.
A plasma protein which is very important for hemostasis, since it inhibits FVIII bind-
ing to membranes and is involved in the construction of the trombocyte-network, is van
Willebrand factor (VWF). Recently it was shown that shear stress induced conforma-
tional changes affect the hemostatic activity of VWF [124]. Thus, VWF plays a key role
in the detection of blood vessel injury and the succeeding start of hemostasis. The exact
effect of shear forces on hemostasis via VWF however is unknown. Various methods to
fluorescently label VWF exist, which allow for its observation. Hence, shear induced
conformational changes and the interplay of conformation and binding properties could
be investigated e.g. by FCS. Fig. 13.1(a) shows an autocorrelation curve of VWF labeled
via antibodies. Upon application of shear forces, this curve should change revealing the
influence of the conformational change on the dynamics of the protein. Binding exper-
iments to endothelial cells or membranes as model systems either in form of vesicles
or of supported lipid bilayers, as performed on FVIII in this work, combined with a
flow chamber could help unravel the influence of shear on VWF binding to endothel
and hence on its role in the establishment of the trombocyte network. Furthermore,
FCS allows for the measurement of the binding of FVIII to VWF as well as to phos-
pholipid membranes. A first binding isotherm of FVIII binding to VWF is shown in
Fig. 13.1(b). A combination of microfluidics and binding experiments with FCS will
reveal the influence of shear flow on the interaction of FVIII, VWF and phospholipid
membranes. The results could then be used to reconstitute and study the kinetics of a
small network consisting of VWF, FVIII, annexin and membrane surfaces. Knowledge
about the influence of shear forces on the interaction of FVIII, VWF and membranes
could also help to understand part of the initiation process of the coagulation cascade,
since in this case activation of FVIII without thrombin is necessary, but so far, the only
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(a) (b)
Figure 13.1: FCS experiments on VWF. (a) Autocorrelation curve (◦) of VWF
labeled via fluorescent antibodies and the corresponding fit (red line). (b) Titration
curve of antibody labeled FVIII binding to unlabeled VWF. The full line represents a
first approximation of a fit to the binding isotherm according to equation 5.18.
known activation mechanism of FVIII is thrombin-mediated. To conclude, FCS could
help to adress the specific questions how shear flow affects the shape of VWF and alters
the biochemical rates of its interactions and thus contribute to a better understanding
of hemostasis.
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